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1. Introduction 
 
1.1. Enterococcus faecalis 
 
Enterococcus faecalis was first described at the end of the 19th century by Thiercelin as 
coccoid bacteria present in the intestinal tract [1, 2]. In the same year, Maccallum and 
Hastings sampled and described an organism that was responsible for a lethal case of 
endocarditis. This organism is nowadays known as Enterococcus faecalis. This finding 
coincidently provided a first detailed description of its pathogenic capabilities [3]. The genus 
Enterococcus was first described by Schleifer and Klipper-Bälz in 1984 [4, 5]. The name 
refers to entero (gut) and coccus (berry). Until 1984 enterococci were classified as 
Streptococcus Lancefield group D. At the beginning only two species were categorized into 
the new genus of Enterococcus, Enterococcus faecium and Enterococcus faecalis, formerly 
referred to as Streptococcus faecalis or Streptococcus faecium, respectively.  
For many years species of Enterococcus have been underestimated as a causative agent for 
infective diseases in both humans and animals. Recently, the numbers of infections caused by 
this pathogen in particular in intensive care units (ICUs) is increasing [6].  
Enterococci are Gram-positive, catalase-negative, non-spore-forming and facultative 
anaerobic bacteria, which normally grow as diplococci or short chains of cocci. Importantly, 
enterococci are a major problem in hospitals and other medical units [7]. Enterococci are able 
to survive a wide range of stresses and hostile environments, including those of extreme 
temperature (5–65°C), a wide range of pH-values (4.5-10.0) and high sodium chloride 
concentration. This unique tolerance to extreme conditions enables them to colonize a wide 
range of niches [8]. Another important characteristic of these bacteria is their ability to form 
biofilms. On blood agar plates enterococci show a very diverse hemolysis phenotype; they 
can be α-, β- or γ hemolytic. Enterococcus usually inhabits the intestinal tract of humans, but 
they are also isolated from the environment and are present in the gut microflora of all 
mammals [9]. 
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FIG. 1.1.: Enterococcus faecalis. Scanning electron microscopy image showing a typical 
enterococcal chain; bar represents 1 µm (taken by Prof. Dr. Manfred Rohde, Helmholtz-Centre for 
Infection Research). 
 
 
The occurrence of different enterococcal species in humans is strongly dependent on age and 
diet. The most frequent species of the genus Enterococcus in humans are Enterococcus 
faecalis and Enterococcus faecium, which account for more than 90% of all clinical isolates. 
Besides E. faecalis and E. faecium there are more than 50 other species in this genus. Other 
enterococci species present in humans are Enterococcus avium, Enterococcus casseliflavus, 
Enterococcus durans, Enterococcus gallinarum, Enterococcus mundtii, and Enterococcus 
raffinosus  [10]. 
 
1.2. Diseases caused by Enterococcus faecalis 
 
Enterococci are part of the normal human fecal flora and widely distributed among humans 
[11], but also among farm animals [12]. Since the beginning of the antibiotic era, these 
bacteria propose major health challenges, including the need for combination antibiotic 
therapy to successfully treat diseases like enterococcal infective endocarditis [10]. In case of 
enterococcal infective endocarditis, the mortality approaches 20% [13]. Diseases caused by 
enterococci are reported as the third most common causes of nosocomial infections in the US 
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and Europe [14, 15]. About 12% of all nosocomial infections in the US and 26.5% of urinary 
tract infections in Germany are caused by this pathogen [16, 17].  
E. faecalis has been reported to be the most common enterococcal species in hospitals and is 
responsible for up to 90% of infections caused by enterococci [6]. If patients are infected with 
E. faecalis, soft tissue wounds or the urinary tract is the predominant site of infection. In the 
beginning 1990s, surgical-site infections of patients caused by E. faecalis have become an 
increasingly important problem in clinical settings [18].   
Besides urinary tract infections [19], these bacteria are responsible for intraabdominal and 
intrapelvic abscesses [20]. E. faecalis is also a serious problem for blood stream infections 
and sepsis [19, 21] and there are also case reports of infections of cellulitis and osteomyelitis, 
the respiratory tract as well as the central nervous system or meningitis [22, 23] and 
underlining the broad spectrum of enterococcal induced diseases.   
 
1.3. Emergence of antibiotic resistance of Enterococcus spp.  
 
Most enterococci are resistant to many antibiotics and can handle many commonly used 
antibiotics like aminoglycosides, aztreonam, cephalosporins, clindamycin, the semisynthetic 
penicillin nafcillin and oxacillin, linezoid, trimethoprim-sulfamethoxazole and quinupristin-
dalfopristin [24, 25].  
The broad-spectrum antibiotic resistance of enterococci is a tremendous problem in the 
clinical context. Especially, the increasing resistances against so-called “last resort-
antibiotics” like vancomycin or teicoplanin propose a major challenge and make an effective 
treatment of enterococcal infections difficult. Only 15 years after the first treatment with 
vancomycin the first case of vancomycin-resistance was observed [15]. This resistance of 
enterococci is becoming more and more common with rapid accumulation of resistances to 
multiple antibiotic classes, for example with glycopeptides antibiotics [7, 8, 15].  
Brown et al. showed that glycopeptide-resistant enterococci elevated the rate of mortality up 
to 52% in patients suffering from enterococci infections [26]. Another challenge is the high 
level expression of β-lactamase and aminoglycoside resistant enterococci in nosocomial 
diseases [27, 28]. Additionally, enterococci are also able to transfer their resistance to other 
unrelated Gram-positive bacteria such as Staphylococcus aureus [29]. 
Furthermore, antibiotic resistance is also an increasing problem in the food industry and 
intensive animal husbandry and not only limited to hospitals [30].   
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1.4. Virulence factors of Enterococcus faecalis 
 
Some virulence factors of pathogens are regulated by virulence coding genes, present in 
specific regions on the genome which are termed pathogenicity islands or PAI [31]. The PAI 
of Enterococcus was first described by N. Shankar et al. in 2001 to be present in the genome 
of a multi-drug-resistant strain called E. faecalis [MMH594] that was collected in a cohort 
study in the 1980s [32]. The PAI contains multiple pathogenicity factors, e.g. the enterococcal 
surface protein (ESP), which is responsible for an increased biofilm formation and 
colonization potential, a cytotoxin, the aggregation substance, a bile acid hydrolase as well as 
other surface proteins and general stress response proteins [33].  
 
1.4.1. Enterococcal surface protein 
Enterococcal surface protein (ESP) is a cell wall-associated protein of E. faecalis isolates 
[34]. It has been demonstrated that the frequency of esp coding gene is more frequent in 
clinical isolates than commensal isolates [35]. ESP enhances the persistence of E. faecalis in 
the urinary bladder during urinary tract infections. This has been studied using isogenic ESP-
deficient mutant strains in comparison to wild-type bacteria in murine infection models [36]. 
This study demonstrated that ESP is an important factor for adherence of enterococci to 
epithelial cells of the urinary bladder through specific factors such as mucin or uroplakin [36]. 
 
1.4.2. Cytolysin 
Enterococcal exotoxin, also called cytolysin, is a cytotoxin that is capable to lyse 
erythrocytes, macrophages and neutrophils [37, 38]. The expression of the cytolysin is 
regulated by a two-component regulatory system via a quorum sensing mechanism [38]. 
Chow et al. described an increasing virulence potential of cytolysin-positive enterococcal 
strains in a rabbit model of endocarditis. In this study the authors found a positive correlation 
between virulence potential and cytolysin expression [39]. A retro-perspectival study showed 
that patients are at a five-fold higher risk to die when infected with cytolysin-positive 
enterococcal strains compared to infections with negative strains [32]. These findings 
underline the importance of enterococcal cytolysins for bacterial pathogenesis. 
 
 
 5 
 
 
 
1.4.3. Aggregation substance 
Another important virulence factor of E. faecalis is the pheromone-inducible surface protein 
aggregation substance (AS) which is essential for bacterial conjugation through promoting 
mating aggregate formation [40]. This strong and close association with other bacteria results 
in an efficient enterococcal donor-recipient plasmid transfer. It has been reported that the 
aggregation substance AS contributes to the pathogenesis of enterococcal infection in vivo 
through various mechanisms [41].  
In addition, AS-expressing enterococci are more resistant to be killed by phagocytic cells like 
macrophages or neutrophils due to an inhibition of reactive oxygen species (ROS) [42]. 
 
1.4.4. Adhesin to collagen binding by E. faecalis  
Another adhesin of E. faecalis is called adhesin to collagen binding by E. faecalis (ACE) and 
binds to the extracellular matrix [43]. ACE is a microbial surface component recognizing 
adhesive matrix molecule (MSCRAMM) on the enterococcal surface and an important 
virulence factor contributing to virulence in urinary tract infection models in vivo [44].  
The function and structure is similar to the staphylococcal collagen binding protein CNA [45]. 
ACE is present in nearly 100% of clinical enterococcal isolates, suggesting that ACE is 
expressed in vivo and contributes to virulence, but not necessary to cause an infection such as 
described in an urinary tract infection [44, 46]. 
 
1.4.5. Gelatinase 
Another important virulence factor from Enterococcus faecalis is an extracellular active 
gelatinase (GelE). This extracellular zinc-metalloprotease is part of a protection mechanism of 
E. faecalis against the host response [47]. GelE is important for resistance to several key 
components of the host innate immune defense system including antimicrobial peptides 
preventing damage to the pathogen [48]. The functional spectrum of GelE includes cleavage 
and degradation of host proteins like LL-37, fibrinogen, fibrin, collage, endothelin-1 and 
bradykinin. Degradation of components of the complement system like C3, C3a and C3b 
results in an inactivation of the complement cascade [47, 49-51]. Previous studies showed that 
GelE-positive strains of Enterococcus faecalis have an increasing potential to establish a 
biofilm [52]. Furthermore, expression of GelE increased the virulence in an animal model of 
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infective-endocarditis [52, 53] as well as in an invertebrate model of E. faecalis infection [54]. 
These findings underline the importance of GelE for host colonization and virulence. 
 
 
1.5. Interaction of E. faecalis with the host immune system 
 
Based on the clinical importance of E. faecalis infections it is surprising that the knowledge 
about the interaction of enterococci with the host immune system is very limited and 
fragmentary.  
Most studies focus on the interaction of E. faecalis with phagocytes like macrophages and 
polymorphonuclear neutrophils (PMNs). A few studies have shown that opsonization of E. 
faecalis and subsequent killing by PMNs plays a crucial role in the host immune response to 
enterococci [55]. Also the translocation of E. faecalis in mice, which could lead to sepsis, is 
depending on functionally active PMNs and macrophages [56]. An AraC-type transcriptional 
regulator called PerA seems to be necessary for E. faecalis to survive intracellularly in 
phagocytes like macrophages [57]. Also Zou et al. showed that E. faecalis inhibits the 
activation of lysosomes by an unknown mechanism, enabling E. faecalis to survive within 
these cells [58]. PerA itself is known to be able to bind to human platelets and seems to be 
also involved to biofilms formation with other substance [59, 60].  
On the host site it was postulated that the TLR/MyD88 signaling pathway plays an important 
role for infection outcome of infections caused by this microorganism [61, 62]. 
 
1.6. Recognition of pathogens by pattern recognition receptors (PRRs) on 
host immune cells 
 
To identify non-host related structures eukaryotic cells are expressing pattern recognition 
receptors (PRRs). These PRRs are an important part of the immune system because they 
allow host immune cells to identify other cells or structures, like microbial agents or 
pathogen-associated molecular patterns (PAMPs), which are conserved structures expressed 
on their surface [63, 64]. 
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FIG. 1.2.: TLR signaling pathway. A detailed but simplified figure of the TLR signaling pathways 
modified from O'Neill, Golenbock [65].  
 
 
PRRs also identify damage-associated molecules pattern (DAMPs) [66]. Mammals have 
evolved many different groups of PRRs, including AIM2-like receptors (ALRs), C-type lectin 
receptors (CLRs), Nod-like receptors (NLRs), RIG-I-like receptors (RLRs), Toll-like 
receptors (TLRs) and intracellular DNA sensors such as cGAS [67]. TLRs are one of the best-
characterized PRRs. They are not only responsible for sensing invading pathogens outside the 
cell but also intracellularly within endosomes and lysosomes [68]. The number of TLRs 
varies from species to species and estimates range from 10-13. In humans ten functional TLRs 
have been identified so far and named TLR1-10. Furthermore a nonfunctional pseudogene 
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called TLR11 has been described. In mice 12 functional TLRs have been reported, named 
TLR1-9 and TLR11-13 [69]. Different TLRs recognize different molecular patterns of 
microorganisms and self-components [66, 70, 71]. 
 
Table 1. Overview of TLRs in mammals 
Receptor Location Ligand Adaptor 
molecule 
TLR2/1 Cell surface triacylated lipoprotein, 
lipopeptide 
MyD88/TIRAP 
TLR2/6 Cell surface LTA from Gram-positive 
bacteria, PGN, diacylated 
lipoprotein, lipopeptide, 
MyD88/TIRAP 
TLR3/3 intracellular viral dsRNA TICAM1 
TLR4/4 Cell surface / 
intracellular 
LPS from Gram-negative 
bacteria, HSP72, S100A8/A9, 
MBD2 
MyD88/TIRAP 
TICAM1/TICAM
2 
TLR5/5 Cell surface bacterial flagellin MyD88 
TLR7/7 Intracellular viral ssRNA MyD88 
TLR8/8 Intracellular viral ssRNA MyD88 
TLR9/9 Intracellular bacterial or viral CpG-DNA MyD88 
TLR10/1,2,10  
(human specific) 
Cell surface ND MyD88 
TLR11/11 
(mouse specific) 
Intracellular  Toxoplasma gondii profiling, 
uropathogenic bacteria 
MyD88 
TLR12/12,11 
(mouse specific) 
Intracellular DNA from Toxoplasma 
gondii  
MyD88 
TLR13 
(mouse specific) 
Intracellular 23S rRNA,  
vesicular stomatitis virus 
MyD88 
 
PGN: peptidoglycan; LPS: lipopolysaccharide; LTA: lipoteichoic acid; HSP: heat shock protein; 
MBD2: murine β-defensin; CpG-DNA: cytosine-phosphate-guanine DNA; MyD88: myeloid 
differentiation primary response gene 88; TIRAP: TIR-domain-containing adaptor protein; 
TICAM: TIR-domain-containing adaptor molecule; ND: not determined [72]. 
 
 
 9 
 
 
1.6.1. Function of Toll-like receptor 2 (TLR2) 
Toll-like receptor 2 (TLR2) is one of the most prominent receptors in the recognition of 
PAMPs of Gram-positive bacteria like lipoteichoic acid (LTA) or peptidoglycan, which 
composes the Gram-positive cell wall [73, 74]. 
TLR2 is expressed on the surface of many different immune cells as well as endothelial cells 
and belongs together with TLR1, TLR5, TLR6, TLR10, and TLR11 to the class of cell 
surface TLRs [66, 75, 76].  
Additionally, TLR2 recognizes also non-microbial ligands, including DAMPs such as high 
mobility group 1 protein (HMGB1) or hyaluronan fragments and other products of inflamed 
tissue [77-80].  
 
 
FIG. 1.3.: TLR2 signaling pathway. TLR2, together with other TLRs, shares the MyD88-
dependent pathway, which finally activates NF-κB, leading to the production of inflammatory 
cytokines like IL-6 and IRF3. Adapted and modified from [81]. 
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TLR2 and TLR4, the latter one being the major receptor for the recognition of Gram-negative 
bacteria, initiates intracellular signaling pathways that lead to activation of transcription 
factors, such as nuclear factor-κB (NF-κB) and interferon regulatory factor 3 (IRF3). This 
activation results in the transcription of genes that are part of immune regulation including 
proinflammatory cytokines, like IL-6, IFN-γ and TNF-α (Fig 1.3) [78]. 
 
1.7. Cells of the innate immune system and their roles in bacterial infections 
 
Innate immunity is the first line of defense against invading microbial pathogens and, 
therefore, the first point of contact. The innate immune defense is an essential first step in 
controlling infectious disease. To establish infections, pathogens evolved strategies to 
overcome this defense. Innate immunity consists of the humoral components such as the 
complement system and also cellular components including PMNs, macrophages, mast cells, 
basophiles, eosinophils and dendritic cells. Resistance mechanisms against the innate immune 
system that enable this commensal organism to become pathogenic are widely unknown. 
Some of the key components of the host innate immune system as well as their role in E. 
faecalis induced infections are described in detail below. 
 
1.7.1. Biology of mast cells 
Mast cells (MCs) are multifunctional and highly effective tissue dwelling cells and an 
important component of the immune system [82]. MCs develop from hematopoietic 
progenitor cells. They circulate in an immature form in the blood stream and undergo a final 
differentiation step by migrating to vascularized tissues where they maturate in the presence 
of stem-cell factors and other cytokines like IL-3 to fully functional cells [83]. Maturated 
MCs are commonly found at sites in the body that are exposed to the external environment 
such as the skin, the lung or the intestinal tract, making these cells important and effective 
sentinels for the immune system to recognize invading microbial pathogens [84]. They also 
are found in close proximity to blood vessels, where they can efficiently regulate vascular 
permeability [85].  
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FIG. 1.4.: Scanning electron microscopy of a bone marrow mast cell (taken by Prof. Dr. Manfred 
Rohde, Helmholtz-Centre for Infection Research). Bar: 2µm. 
 
 
Even though they do not have direct cell-cell contact with antigen-presenting cells, MCs can 
modulate the behavior and recruitment of other neighboring effector cells through the release 
of immunological active mediators [86]. There are four main classes of mediators released by 
MCs, which are released in a process called degranulation. The four classes are 1
st
 cytokines 
and 2
nd
 chemokines, which are produced and pre-stored in granular compartments. The 3
rd
 
class are newly generated lipid-mediators and 4
th
 are endogenous antimicrobial agents such as 
antimicrobial peptides or reactive oxygen species (ROS) [87]. 
These components can mediate a variety of antimicrobial activities such as the coordination of 
immune cell recruitment to the site of infection [87] or the release of antimicrobial peptides 
like the cathelicidin LL-37 [88]. 
 
 
Table 2. Mediators released by mast cells 
Mediators released by mast cells and their function activity 
Granule associated Histamine, serotonin Alteration of vascular permeability 
Different proteases Remodel tissues and recruit effector 
cells 
Lipid-derived LTC4, LTB4, PGD2, PGE2 Recruit effector cells, regulate immune 
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Mediators released by mast cells and their function activity 
response, promote angiogenesis 
Cytokines TNF-α, IL-3, IL-6, IFN Induce inflammation 
IL-10, TGF, VEGF Regulate inflammation and 
angiogenesis 
Chemokines CCL 2, 3, 4, 5, 11, 20 Recruit effector cells and regulate 
immune responses 
CXCL 1, 2, 3, 8, 9, 10, 11 Recruit effector cells and regulate 
immune responses 
Others Nitric oxide and 
superoxide radicals 
bactericidal 
Antimicrobial peptides 
like LL-37 
bactericidal 
 
Furthermore, several studies have shown that MCs are able to phagocytize numerous Gram-
negative bacteria [89] and that they are also able to kill several Gram-positive bacteria by 
extracellular mechanisms like Streptococcus pyogenes [88] or Staphylococcus aureus [90].  
For a long time, MCs were only seen as part of allergic reactions and their activation during 
parasitic infections, but not as a benefit for the host in bacterial, viral or fungal infections [86, 
91, 92]. However, MCs are more and more recognized as a crucial part in the response to 
bacterial infections due to the release of pre-stored and newly synthesized inflammatory 
mediators as well as antimicrobial components [93].  
 
1.7.2. Response of mast cells to microbial pathogens 
Besides their known role in the initiation of allergic reactions, chronic inflammatory processes 
and activation during certain types of parasitic infections [91, 92], no clear evidence 
demonstrates that MCs also play a prominent role in the early immune response to invading 
pathogens [93, 94]. 
MCs employ many different mechanisms in response to invading microbial pathogens. MCs 
are able to recognize opsonized bacteria and phagocytize them. Sher and his colleagues were 
one of the first researchers who studied the phagocytotic behavior of MCs in the late 1970s 
with heat-killed Salmonella enterica serovar Typhimurium [95]. They could show that heat-
killed S. typhimurium incubated in rat serum lead to an opsonization with iC3b which is 
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recognized through the complement receptor 3 of MCs. This recognition in turn leads to an 
activation of MCs.  
Malaviya et al. showed phagocytic activity of MCs with other enterobacteriaceae such as 
Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae [96]. 
In addition to the intracellular activity, MCs have also an extracellular killing mechanism. 
Von Köckritz-Blickwede showed that MCs release extracellular trap that are similar to 
neutrophil extracellular traps (NETs) to trap and ensnare bacteria [97]. These structures were 
named mast cell extracellular traps (MCETs). 
MCs contain a lot of antimicrobial peptides, which are released upon infection. One of these 
components is the cathelicidin LL-37 [88, 98]. The full function of this antimicrobial peptide 
on bacterial surfaces is not fully understood yet, but treatment with LL-37 resulted in a 
surface deformation of Gram-positive bacteria like S. pyogenes [99].  
Beside these direct interactions with bacteria, MCs are also important immunomodulatory 
cells. They are involved in the recruitment of other immune cells like neutrophils by the 
release of a broad-spectrum proinflammatory cytokines including TNF-α or IL-6 in vitro and 
in vivo [100-102]. Nevertheless, the role of these innate immune cells in the course of many 
bacterial infections is still poorly understood and requires more and intensive research.   
 
1.7.3. Biology of dendritic cells 
The immune system is divided into the innate immune system and the adaptive immune 
branch coordinated by specific immune cells of which dendritic cells (DCs) are of central 
importance. 
DCs are able to sense microbial pathogens as well as microbial products and initiate an 
effective immune response against pathogens [103]. 
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FIG. 1.5.: Scanning electron microscopy of immature dendritic cells in the bone-marrow (taken by 
Prof. Dr. Manfred Rohde, Helmholtz-Centre for Infection Research). Bar: 10µm 
 
 
The maturation status of DCs is in particular characterized by the production of the 
inflammatory cytokines interleukin 12 (IL-12) as well as by the upregulation of the 
costimulatory molecules CD40, CD80 & CD86 [104, 105]. These markers are often used to 
discriminate functional DCs, which are important for priming T-cells [106].   
Just like many antigen presenting cells DCs are able to release IL-12 during infection in vitro 
and in vivo. IL-12 is an important cytokine, which is crucial to trigger the differentiation of 
naive CD4
+
 T-cells into T-helper 1 cells (TH-1) [105, 107]. In response to pathogens, DCs are 
important in infections caused by the human pathogens S. pyogenes, S. aureus or Listeria 
monocytogenes by inducing a protective immune response [107-109]. Despite the important 
function as a sentinel cell [105] and the initiation and mounting of an effective innate immune 
response against several pathogenic bacteria, the knowledge of the function and role of these 
cells in the cause of E. faecalis infections is still incomplete. 
 
1.7.4. The role of dendritic cells during microbial induced infections 
Dendritic cells are antigen-presenting cells (APCs). To present antigens on their surface, these 
cells phagocytize and process antigens from their environment. In contrast to other phagocytic 
active antigen-presenting cells like neutrophils or macrophages, which are strongly involved 
in the elimination of invading microorganisms, the main function of DCs is to preserve and 
present antigen information [110]. Antigens are loaded intracellularly on the MHC-II complex 
and transported to the surface where they are presented to T-cells [111]. 
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FIG. 1.6.: Maturation of DCs. The maturation of dendritic cells is triggered by many different 
factors, generated by other immune cells like macrophages, epithelial cells, fibroblast and mast 
cells when these cells encounter microbial organisms or agents and become activated. They 
produce type 1, type 2 or regulatory-type PAMPs and tissue factors (TF) which leads to different 
stages of matured DCs which in turn prime naïve CD4
+
 T-cells into TH-1, TH-2 or regulatory T-
cells (TREG-cells) [112].  
 
 
This mechanism is very important to mount an effective immune response and to induce the 
differentiation and proliferation of cells of the adaptive immune system like TH-1 cells [106].  
However, DCs are capable to elicit a strong killing ability, for example in the immune 
response against Streptococcus pyogenes [113].  
Recognition of microbes by DCs is mediated through different PRRs such as TLRs [67, 114]. 
TLRs are important members of the IL-1 receptor/TLR superfamily. TLRs recognize the 
presence of microbial pathogens via the detection of conserved microbial structures called 
PAMPs [67]. The maturation of DCs can directly be initiated by the activation of TLRs [114]. 
While most TLRs act through MyD88 [115], some of them like TLR4 recognizing LPS 
induce maturation in a MyD88 independent manner [114].  
The interactions of TLRs with their target motifs as well as the intracellular signaling 
cascades are discussed more into detail in section 1.6. and are mostly depending on the 
adapter molecule MyD88. Studies using MyD88 knockout systems have shown the 
importance of this pathway for the activation and the maturation of fully functional DCs [116-
118].  
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DCs also mature indirectly and independent of pathogenic stimuli by sensing a large number 
of inflammatory-associated factors like e.g. MIP-1α and MIP-1β from infected endothelial 
cells [112, 119].  
Once DCs are maturated, they migrate to the lymphatic system. Here they present the antigens 
loaded onto class II MHC to T-cells and prime them into different classes like TH-1, TH-2 or 
TREG-cells [120], an important step in the initiation of an adaptive immune response. 
 
1.8. Endothelial cells as part of the immune system 
 
1.8.1. Biology of endothelial cells 
As an essential source for cytokine production, the endothelium is an important part of the 
host innate immune response. It also is the natural barrier covering the interior blood- and 
lymphatic vessel system [121]. Endothelial cells (ECs) grow in a confluent monolayer and 
appear as cobblestone. This form can be changed through culturing them under shear stress so 
they elongate in flow direction [122, 123].   
Endothelial cells (ECs) and cells of the hematopoiesis have a common origin. Cells with tek-
expression – a receptor tyrosine kinase – seems to be linked to the EC linage while c-myo 
expression is linked to the hematopoietic cell differentiation [124]. 
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FIG. 1.7.: Scanning electron microscopy of a confluent monolayer of human umbilical vein 
endothelial cells cultured for 120h under flow conditions (taken by Prof. Dr. Manfred Rohde, 
Helmholtz-Centre for Infection Research). Bar: 20µm 
 
 
ECs are characterized by different molecules presented on their surface like platelet-
endothelial cell adhesion molecule 1 (PECAM-1 or CD31), CD34, glycoprotein Ia, IIa, IIIa 
and P-selectin (CD62P) and in addition by intracellular factors like platelet-derived growth 
factor, transforming growth factor-β and von-Willebrand-factor which are pre-stored in so 
called Weibel-Palade bodies [125, 126]. ECs are also identified by the uptake of acetylated 
low-density lipoprotein (LDL) and the expression of factor 8 [127]. 
Other important surface molecules expressed on ECs are intercellular adhesion molecule 1 
(ICAM-1 or CD54), E-selectin (CD62-E), vascular cell adhesion protein 1 (VCAM-1 or 
CD106) and mucosal addressin cell adhesion molecule 1 (MAdCAM-1) which are necessary 
for the migration process of leukocytes over the endothelial layer [128].   
ECs produce a broad spectrum of different factors, which are necessary for the regulation of 
blood pressure, flow rate, angiogenesis, coagulation, growth regulation and production of 
extracellular matrix proteins [125, 129]. ECs also release important components, e.g. IL-6 and 
IL-8, which are responsible for inflammatory immune processes like neutrophil recruitment 
and activation [130-133]. 
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1.8.2. Anti-pathogenic functions of endothelial cells  
Endothelial cells are autocrine for cytokines and produce a broad spectrum of pro- and anti-
inflammatory cytokines (Table 3.) [134-137]. Besides to the recruitment of immune cells like 
PMNs the endothelium is involved in a process called “rolling” of leukocytes involving cells 
like PMNs. This rolling process is based on the expression of a small number of surface 
proteins on ECs. In the initial step rolling involves the binding of PMNs to E- and P-selectin 
presented on the surface of ECs. This leads to an enhanced exposure of PMNs to cytokines 
and chemokines because of the release by the endothelium [138, 139]. In a second step, the 
leukocyte rolling process starts. Integrins are expressed on the surface of PMNs, which 
increases the adhesion between PMNs and ECs [138, 140]. The next step is characterized by 
the migration of PMNs along the endothelium. In this step, the connection to the EC is based 
on the interaction of LFA-1/ICAM-1, VLA-4/VCAM-1 and a4b/MAdCAM-1. The last step in 
the rolling process of PMNs is the transmigration into the sub-endothelium space. The 
initiation of transmigration is ICAM-1 depended [141] while the actual step is characterized 
by weakening the tight junction between single endothelial cells. The molecular basis of this 
process is still not fully understood, but there are indications that an intracellular increase of 
Ca
2+
 leads to an activation of p38 and a signaling via ICAM-1 binding in turn results in an 
activation of RhoA and both enhance the potential of PMN transmigration [142-144]. The 
expression of adhesion molecules on the surface of ECs enables PMNs to reach the site of 
infection and to combat invading microbial pathogens. 
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FIG 1.8.: Simplified model of the rolling process of leukocytes along the endothelium. The 
process is divided in three steps: (1) attachment – leukocytes binds to surface presented E- and P-
selectin; (2) activation – the binding become stronger by expression of integrins on EC surface and 
leukocytes start migration over EC; (3) transmigration – leukocytes go deeper into sub-endothelial 
space. Modified from Lawson et al. [128] 
 
 
ECs have a direct antimicrobial effect against pathogens by the release of antimicrobial 
peptides like human β-defensin 3 [145] and RNase7 [145, 146]. 
Additionally, ECs are able to modify their permeability and stiffness. This process is 
regulated by LL-37. Byfield and colleagues showed a concentration-dependent increase in 
stiffness by LL-37 whereas at the same time the permeability was reduced [147]. These 
modifications could protect the host from spreading bacteria like Streptococcus pyogenes, 
Corynebacterium diphtheriae or Leptospira interrogans [148-150].  
 
Table 3. Released components by endothelia cells 
Mediator released by endothelia cells 
Cytokine IL-1; IL-3; IL-6; IL-8; IL-11; IL-15; TGF-β; TNF-α 
Chemokines CXCL-1; CCL-2 
Other released components GM-CSF 
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1.9. Aim of this study 
 
The aim of this study was to enhance the understanding of molecular and cellular factors and 
processes involved in host responses to infections caused by the nosocomial pathogen E. 
faecalis. This pathogen rapidly becomes an increasing threat in ICUs and is of rising 
importance as a reason for nosocomial infections and is producing as a result increasing costs 
in the health care system.  
A major focus of this study is how cells of the innate immune system respond to infections 
caused by this pathogen and which resistance mechanisms and strategies E. faecalis employs 
to circumvent these host defense strategies. This interplay is of particular significance due to 
the shift from a commensal to a pathogenic organism. 
Because studies in particular in terms of enterococcal interactions with host innate immune 
cells, like mast cells (MCs), dendritic cells (DCs) or the endothelial barrier are insufficient so 
far the central interest of this study was to gain deeper insights into these interactions.  
Another part of this thesis focused on the receptors and signaling pathways involved in 
response to this microorganism, in particular the role of PRRs in the recognition of 
enterococci by host immune cells. 
The results of this study contributes to a better understanding of the interactions of E. faecalis 
with the cellular compartment of the host innate immune system as well as to gain further 
insights into the pathogenicity of E. faecalis infections and the role of cells of the innate 
immune response in the course, development and resolution of E. faecalis induced diseases. 
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2. Materials and Methods 
2.1. Chemicals 
Agarose  ROTH 
Ammonium chloride  MERCK 
Alexa-Fluor 488 Phalloidin  THERMO-FISHER 
BEA (bile esculin agar)  BROTH 
β-mercaptoethanol  MERCK 
BSA (bovine serum albumin)  SIGMA 
BHI (brain heart infusion)  ROTH 
Cacodylate  ROTH 
Calcium chloride  ROTH 
Carboxyfluorescein  SIGMA 
Comp 48/80  SIGMA 
Cromolyn  SIGMA 
Cytocalasin D  SIGMA 
DAPI (4′,6-Diamidin-2-phenylindol)  SIGMA 
Disodium hydrogen phosphate  MERCK 
DTNB  SIGMA 
EDTA  GIBCO 
Ethanol  LIV 
Glucose  ROTH 
Glutaraldehyde  ROTH 
Glycerol  MP 
Hematoxylin  MERCK 
Heparin  ROCHE 
HEPES  GIBCO 
Isopropanol  LIV 
L-Glutamine  GIBCO 
Magnesium chloride  ROTH 
N-carbobenzoxy-lysine thiobenzyl ester  SIGMA 
OptiPrep  AXIS-SHIELD 
PBS (phosphate buffered saline)  SIGMA 
PFA (paraformaldehyde)  FLUCA 
PNAG (p-nitrophenyl N-acetyl-β-D-glucosamide)            SIGMA 
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Poly-l-lysine  SIGMA 
Potassium chloride  MERCK 
Potassium dihydrogen phosphate  MERCK 
Potassium hydrogen carbonate  MERCK 
ProLong Slowfade + DAPI  INVITROGEN 
RLT-Buffer  QIAGEN 
RNase free water  GIBCO 
Saponin  SIGMA 
Sodium azide   SIGMA 
Sodium dihydrogen carbonate  MERCK 
Sodium chloride  MERCK 
Sulfuric acid   ROTH 
TMB  MERCK 
TPA  MERCK 
Toluidine-Blue  ROTH 
TRIS  ROTH 
Triton X-100  SIGMA 
Trypan blue  SIGMA 
Tween20  ROTH 
Yeast extracts  BECTON, DICKINSON 
 
2.2. Devices and consumables 
2.2.1. Devices 
Agarosegel-electrophoresis chamber  GIBCO 
Autoclave  TECNOMARA 
Centrifuges: 
-5417 R   EPPENDORF 
-MEGAFUGE 1.0   HERAEUS 
Clean bench  THERMOFISHER  
Cuvette  ROTH 
ELISA-Reader Sunrise  TECAN 
Flow-Cytometry Units: 
-FACSCalibur  BECTON DICKINSON 
-LSR II  BECTON DICKINSON 
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Frezzer (-20°C & -80°C)  LIEBHERR 
Fridge  LIEBHERR 
Heatblock  EPPENDORF 
Horizontal  SARTORIUS 
Incubators: 
- CO2 Incubator  HERAUES 
- Scientific water mantled incubator 3111  FORMA 
Microscope:  
-EM Microscope DSM982 Gemini  ZEISS 
-EM 910 Transmission-electron-microscope  ZEISS  
-Axiophot microscope with an attached Axiocam HRc   ZEISS 
 digital camera  
Microwave  BROTHER 
PCR-Cycler  EPPENDORF 
pH-Meter  SCHOTT 
Photometer Novaspec II  PHARMACIA LKB 
Pipette (10 µL; 20 µL; 100 µL; 200 µL; 1000 µL)  EPPENDORF 
Vortex mixer  HOBEIN 
Water bath (heated)   KÖTTERMAN 
 
2.2.2. Consumables     
96-well micro-titer plates  SARSTEDT 
Cannula  BRAUN 
Cell culture plates (4, 6, 24, 48 wells)  SARSTEDT 
Cell strainer  SIGMA 
Falcon Tube (15 ml; 50 ml)  SARSTEDT 
Gloves (latex; nitrile)  SHIELD-SCIENTIFIC 
Microtiter plate   NUNC 
Petri dish  SARSTEDT 
Pipette tips  EPPENDORF 
Reaction vessels (0.2 µL; 1.5 ml; 2 ml)  EPPENDORF 
Syringe (1 ml; 5 ml; 20 ml)  BRAUN 
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2.3. Antibodies, enzymes and sera 
2.3.1 anti-human 
anti-human CD54 Pacific Blue   BIOLEGEND 
anti-human CD54, purified   BIOLEGEND 
anti-human CD62E APC   BIOLEGEND 
anti-human CD62E, purified   BIOLEGEND 
anti-human CD106 PE   BIOLEGEND 
anti-human CD106, purified   BIOLEGEND 
anti-human IL-1β, purified    BIOLEGEND 
anti-human IL-1β, biotinylated   BIOLEGEND 
anti-human IL-6, purified   BIOLEGEND  
anti-human IL-6, biotinylated   BIOLEGEND  
anti-human IL-8, purified   BIOLEGEND 
anti-human IL-8, biotinylated   BIOLEGEND 
anti-human MCP-1, purified    BIOLEGEND 
anti-human MCP-1, biotinylated   BIOLEGEND 
anti-human TNF-α, purified   BIOLEGEND 
anti-human TNF-α, biotinylated   BIOLEGEND 
 
2.3.2 anti-mouse 
anti-mouse CD11b PE/Cy7       BIOLEGEND 
anti-mouse CD11b PE   BIOLEGEND 
anti-mouse CD11c Alexa Flour 647   BIOLEGEND 
anti-mouse CD11c FITC   BIOLEGEND 
anti-mouse CD11c PE   BD PHARMINGEN 
anti-mouse CD16/CD32   BD PHARMINGEN 
anti-mouse CD29 Alexa Flour 488   MILTENY BIOTEC 
anti-mouse CD40 Alexa Flour 488   BIOLEGEND 
anti-mouse CD80 PE/Cy5   BD PHARMINGEN 
anti-mouse CD86 PE/Cy7   BIOLEGEND 
anti-mouse CD117-PE   BD PHARMINGEN 
anti-mouse F4/80 FITC   BIOLEGEND 
anti-mouse F4/80 PE   BIOLEGEND 
anti-mouse IL-6, purified   BIOLEGEND 
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anti-mouse IL-6, biotinylated   BIOLEGEND 
anti-mouse IL-10, purified   BIOLEGEND 
anti-mouse IL-10, biotinylated   BIOLEGEND 
anti-mouse IL-12 p70, purified   BIOLEGEND 
anti-mouse IL-12 p70, biotinylated   BIOLEGEND 
anti-mouse IFN-γ, purified   BD OptEIA™ 
anti-mouse IFN-γ, biotinylated   BD OptEIA™ 
anti-mouse KC, purified   BD PHARMINGEN 
anti-mouse KC, biotinylated   BD PHARMINGEN 
anti-mouse Ly6G / Ly6C Alexa Flour 488   INVITROGEN 
anti-mouse Ly6C PE   INVITROGEN 
anti-mouse MIP2, purified   BD PHARMINGEN 
anti-mouse MIP2, biotinylated   BD PHARMINGEN 
anti-mouse TNF-α, purified   BD OptEIA™ 
anti-mouse TNF-α, biotinylated   BD OptEIA™ 
anti-mouse TLR2 Alexa Flour 488   BIOLEGEND 
 
2.3.3 Sera, fluorescence antibody and other enzymes  
Bovine serum albumin   ROTH 
Goat anti-rabbit IgG Alexa Flour 488   INVITROGEN 
Goat anti-rabbit IgG Alexa Flour 568   INVITROGEN 
Goat anti-mouse IgG1    BIOLEGEND 
Rabbit anti-E. faecalis Serum   PINEDA 
Streptavidin-HRP   BD OptEIA™ 
Fetal Calf Serum   GIBCO 
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2.4. Primers and Probes 
Table 4. Primer-list human 
Name Forward Reverse Sequence Annealing 
Temperature 
[°C]  
  CD54 
 
X  5´-TGG TAG CAG CCG CAG TCA 
TA-3´ 
 
60 
 X 5´-CTC CTT CCT CTT GGC TTA 
GT-3´  
 
60 
CD62E X  5´-AAC TTC CAT GAG GCC AAA 
CG-3´  
 
54 
 X 5´-TTG TCG TTG CCA GTG TTC 
AG-3´ 
 
54 
CD106 X  5´-CCC TTG ACC GGC TGG AGA 
TT-3´ 
 
60 
 X 5´-TGG GGG CAA CAT TGA CAT 
AAA GTG-3´ 
 
60 
β-actin X  5´-TGG AAT CCT GTG GCA TCC 
ATG AAA C-3´ 
 
52-60 
 X 5´-TAA AAC GCA GCT CAG TAA 
CAG TCC G-3´ 
52-60 
 
 
Table 5. Primer-list Enterococcus spp. 
Name Forward Reverse Sequence Reference  
  cylA 
 
X  5´-GGT TAT GCA TCA GAT 
CTC TCA   A-3´ 
 
[151] 
 X 5´-CTG TAT ATA ATC TAC 
TTT TTC AGA AGA TAA 
TTC-3´  
 
 
cylLL X  5´-CTG TTG CGG CGA CAG 
CT-3´  
[151] 
 X 5´-CCA CCA ACC CAG CCA 
CAA-3´ 
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Name Forward Reverse Sequence Reference  
gelE X  5´-CGG AAC ATA CTG CCG 
GTT TAG A-3´ 
 
[151] 
 X 5´-TGG ATT AGA TGC ACC 
CGA AAT-3´ 
 
 
esp X  5´-GGA ACG CCT TGG TAT 
GCT AAC-3´ 
[151] 
 X 5´-GCC ACT TTA TCA GCC 
TGA ACC-3´ 
 
 
ace X  5´-CGG CGA CTC AAC GTT 
TGA C-3´ 
[151] 
 X 5´-TCC AGC CAA ATC GCC 
TAC TT-3´ 
 
 
asa 
 
X  5´-GAT ACA AAG CCA ATG 
TCG TTC CT-3´ 
 
[151] 
 
 
X 
 
5´-TAA AGA GTC GCC ACG 
TTT CAC  A-3´ 
 
ebpA X  5´- CAA CAA CAC CAG 
GGC TTT TTG-3´ 
 
[152] 
 X 5´-ACC GGA CCA GTC AAC 
GAC TAA G-3´ 
 
 
ebpB X  5´-CGT ACA GGC GGC AAG 
TCT TT-3´ 
 
[152] 
 X 5´-AGG TAT TCC CCC GCT 
TGA TTT-3´ 
 
 
ebpC X  5´-GCG GCA CAC TAA AAT 
TCG TTT A-3´ 
 
[152] 
 X 5`-GTC GTC GGT ATG ACC 
GTT ATC  A-3´ 
 
 
hyl X  5´-ACA GAA GAG CTG 
CAG GAA   ATG-3´ 
 
[153] 
  X 5´-GAC TGA CGT CCA AGT 
TTC CAA-3´ 
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2.5. Cell culture and nutrient solutions 
All buffers were stored at room temperature unless otherwise stated. 
  
2.5.1.1. Iscove’s Modified Dulbecco’s Media (IMDM) 
Iscove’s medium was supplemented with 10% (v/v) heat-inactivated FCS (30 minutes, 65°C), 
2 mM L-glutamine, 10 mM HEPES buffer, 5% (v/v) NEAA and 100 µg/l of 
penicillin/streptomycin. 
 
2.5.1.2. Dulbecco's Modified Eagle's Medium 
Dulbecco’s medium was supplemented with 5% (v/v) heat-inactivated FCS (30 minutes, 
65°C), 2 mM L-glutamine and 10 mM HEPES buffer. 
 
2.5.1.3. Endothelia Cell Medium for cultivation 
Endothelia cell medium was supplemented with 10% (v/v) heat-inactivated FCS (30 minutes, 
65°C) and manufacture typical BulletKit
TM
 was added for cultivation of all HUVECs. 
 
2.5.1.4. Endothelia Growth Medium-1 (EBM-1) 
Endothelia growth medium-1 was supplemented with 10% (v/v) heat-inactivated FCS (30 
minutes, 65°C). Additionally, it BulletKit
TM
 was added for cultivation of HUVECs from 
ScienCell then called ECM. In case of HUVECs from Lonza called EGM-1 
 
2.5.1.5. Endothelia Growth Medium-2 (EBM-2) 
Endothelia growth medium-2 was supplemented with 10% (v/v) heat-inactivated FCS (30 
minutes, 65°C Additionalyl, it BulletKit
TM
 was added for cultivation of HUVECs from 
PromoCell then called EGM-2. 
 
2.5.2. Brain-Heart-infusion (BHI) medium  
2.5.2.1. BHI-bouillon 
BHI  37 g 
ddH2O  ad 1000 ml 
The medium was autoclaved (15 minutes, 2*10
5
 Pa at 121°C) before use. 
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2.5.2.2. BHI-agar 
BHI included agar  52 g 
ddH2O  1000 ml 
The medium was autoclaved (15 minutes, 2*10
5
 Pa at 121°C) before use. 
 
2.6. General buffers and solutions 
 
2.6.1. 1% agarose gel  
Agarose  1.0 g 
1x TAE  100 ml 
 
2.6.2. 50x TAE buffer 
Tris-HCl  242.0 g  
EDTA  18.60 g 
Glacial acetic acid  57 ml 
dH2O  ad 1000 ml 
The buffer was autoclaved (15 minutes, 2*10
5
 Pa at 121°C). 
 
2.6.3 Cacodylate buffer  
Cacodylate  13.8 g 
CaCl2  1.29 g 
MgCl2  0.95 g 
The pH was adjusted to pH 6.9. 
 
2.6.4 PBS 
Sodium chloride  8.0 g 
Disodium hydrogen phosphate  1.4 g 
Potassium dihydrogen phosphate  1.0 g 
Potassium chloride  1.0 g 
ddH2O  ad 1000 ml 
The pH was adjusted to 7 with NaOH and the buffer was then autoclaved (15 minutes, 2*10
5
 
Pa at 121°C). 
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2.6.5. Solution C  
BSA  0.50 g 
NaCl  0.88 g 
The pH was adjusted to pH 7.4. 
 
2.6.6. Solution for cell lysis (RLT buffer) 
10 μL β-mercaptoethanol were added to 1 ml RLT buffer  
(Ready to use from RNeasy® Mini Kit QIAGEN) 
 
2.6.7. Solutions for ELISA  
2.6.7.1. Coating buffer for IL-1β, IL-6 and TNF-α 
Sodium carbonate  10.6 g 
ddH2O  ad 1000 ml 
The pH was adjusted to 9.5. 
 
2.6.7.2. Coating buffer for KC and MIP2  
1x PBS  
 
2.6.7.3. Coating buffer for IL-12 p70 and IL-10 
Di-sodium hydrogen-phosphate   14,1960 g 
ddH2O  ad 1000 ml 
The pH was adjusted to 7.5. 
 
2.6.7.4. Blocking buffer 
1x PBS with 10% FCS 
 
2.6.7.5. Washing buffer 
1x PBS with 0.05% Tween20  
 
2.6.8. Solutions for β-hexosaminidase assay 
2.6.8.1 Citrate buffer  
Citric acid         7,6850 g  
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Na2HPO4·7H2O       5,3620 g 
Glycine         30,027 g 
Triton X-100         0,1 ml 
2.6.8.2 PNAG          
PNAG         5g/l  
PNAG was dissolved in citrate buffer. Due to poor solubility of PNAG in citrate buffer, 
shacking and mild heating (37-40°C) of PNAG were required for complete dissolving of 
PNAG This process can take up to 3h. The solution is stable for 24h. 
 
2.6.8.3. Tyrode’s buffer 
1M HEPES  10 ml 
Sodium chloride  7.540 g 
Potassium chloride  0.370 g  
Calcium chloride  0.206 g 
Magnesium chloride  0.203 g 
Glucose  1.008 g 
BSA  1.000 g 
Heparin  100 µg/ml 
ddH2O   ad 1000 ml 
The solution was filtered through a 0.2 µm filter and stored at 4°C. 
 
2.6.9. TE buffer 
Tris-HCl (pH 8.0)  20 mM 
EDTA  1 mM 
ddH2O  100 ml 
The solution was autoclave (15 minutes, 2*10
5
 Pa at 121°C) before use. 
 
2.7. Growth factors and antibiotics 
 
GM-CSF  BIOLEGEND 
mSCF  CELL SIGNALING 
mIL-3  BIOLEGEND 
mIL-4  BIOLEGEND 
Doxycycline  SIGMA 
 32 
 
Erythromycin  INVITROGEN 
Gentamicin  GIBCO 
Penicillin  INVITROGEN 
Streptomycin  INVITROGEN 
 
2.8. Kits 
 
DNA-free™ Kit for DNA depletion  AMBION 
High Capacity cDNA Reverse Transcription kit  APPLIED BIOSYSTEMS 
LIVE/DEAD
ʀ 
BacLight
TM 
Bacterial/Viability Kit   INVITROGEN 
RiboPure Bacteria RNA Extraction Kit  AMBION 
RNeasy ® Mini Kit  QIAGEN 
SensiFAST™ SYBR & Fluorescein One-Step Kit  BIOLINE 
 
2.9. Bacteria strains 
Table 6. E .faecalis strains and other bacteria 
ATCC strain No. / internal Source Reference 
47077 / E. faecalis OG1RF ATCC  
47077+pMV158gfp / E. faecalis GFP Kindly provided by NIETO, C. 
and ESPINOSA, M.; Madrid, 
Spain 
[154] 
 
Staphylococcus aureus SH1000 Kindly provided by FOSTER, S.; 
Sheffield, England 
[155] 
98579 / Escherichia coli TOP10 ATCC  
 
2.10. Bacterial culture 
 
2.10.1. Growth conditions 
E. faecalis stock cultures were maintained at –80°C, and cultured at 37 °C in BHI-medium for 
6 h. S. aureus stock cultures were maintained at –80°C, and cultured at 37 °C in BHI-medium 
for 6 h. E. coli stock culture were maintained at –80°C, and cultured at 37 °C in LB-medium 
for 6 h. 
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2.10.2. Inoculum preparation 
Bacteria were collected at mid-log phase (absorbance at OD600nm~0.5) and harvested by 
centrifugation for 10 minutes at 4,000 rpm (HERAEUS MEGAFUGE 1.0). Bacteria were 
washed once with sterile 1x PBS and adjusted to 15% transmission at 600 nm (PHARMACIA 
LKB Novaspec II) using sterile 1x PBS. This is equal to 10
9
 bacteria/ml. To heat-kill bacteria, 
bacteria were boiled for 1h at 95°C. Bacteria suspensions were further diluted in cell culture 
medium depending on cell type or 1x PBS for in vivo infection experiments to achieve the 
required inoculum concentration. For in vitro infection experiments, a multiplicity of infection 
(MOI) of ten bacteria per eukaryotic cell (10:1) was used, except were indicated differently.  
 
2.11. Preparation and culture conditions of eukaryotic cells 
 
2.11.1. Preparation and culture of primary murine bone-marrow derived mast cells 
(BMMCs) 
Mouse bone-marrow-derived mast cells were used from bone marrow extruded from the 
femur and tibia of C57BL/6 wild-type, TLR2 knock-out mice or MyD88 knock-out mice. 
Bone marrow was flushed out of the bones by using a 23G syringe with warm
 
complete 
IMDM and cultured in the presence of murine IL-3 (mIL-3,BIO LEGEND) at a concentration 
of 5 ng/ml, supplemented with 100µg/ml penicillin/streptomycin for 3 weeks at 37 °C, 5% 
CO2 (FORMA scientific water mantled incubator 3111). After 3 weeks, the differentiation 
status of BMMCs was checked by FACS analysis using the surface marker CD117. Cells 
were used if at least 95% purity regarding CD117 expression was achieved. Mast cell culture 
was maintained with murine steam cell factor (mSCF, CELL SIGNALING) in a concentration 
of 50 ng/ml instead of murine IL-3 for up to 6-8 weeks 
Cells were harvested, counted (Neubauer chamber), adjusted to 1x 10
6 
per ml and used for 
experiments, except where noted differently. 
 
2.11.2. Preparation and culture of primary murine bone marrow derived dendritic cells 
(BMDCs) 
Murine bone marrow dendritic cells were used from bone marrow extruded from the femur 
and tibia of Balb/c wild-type mice or TLR2 knock-out or MyD88 knock-out mice with a 
C57BL/6 background. Bone marrow was flushed out of the bones by using a 23G syringe 
with warm complete RPMI and cultured in the presence of murine IL-4 (mIL-4, 
BIOLEGEND) at a concentration of 10 ng/ml and 50 ng/ml granulocyte-macrophage colony-
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stimulating factor (GM-CSF, BIOLEGEND) supplemented, with 100 µg/ml 
penicillin/streptomycin for 8 days at 37°C, 5% CO2 (FORMA scientific water mantled 
incubator 3111). After 8 days the cells were enriched using an OptiPrep
TM
 gradient according 
to the manufacturer’s instructions. 
The differentiation status of BMDCs was checked by flow cytometry analysis using the 
surface marker CD11c
high
. Cells were used if at least 90% purity regarding CD11c expression 
was achieved.  
Cells were harvested, counted (Neubauer chamber), adjusted to 1x 10
6 
per ml and used for 
experiments, except where stated differently. 
 
2.11.3. Culturing of primary human umbilical vein endothelia cells (HUVECs) 
HUVECs were sub-cultured when 80% confluence was reached. For sub-cultivation, cells 
were washed twice with 4 ml warm HEPES-BSS (SIGMA) to remove dead cells, cell debris 
and medium components. Then 3 ml Trypsin/EDTA (SIGMA) were added to detach cells 
from the cell culture dish. Trypsin treatment was stopped by the addition of 3 ml Trypsin-
Neutralization Solution (TNS) (SIGMA). The detached cells were carefully removed from the 
petri dish, centrifuged 10 min at 180 x g and resuspended in 4 ml fresh EGM-1 for HUVEC 
from LONZA, EGM-2 for HUVEC from PROMOCELL or ECM for HUVEC from 
SCIENCELL. Harvested cells were counted (Neubauer chamber), adjusted to 5 x 10
4
 per ml 
in 10 cm culture-dishes (SARSTEDT) and incubated at 37°C and 5% CO2 until passage five 
or used for experiments, except described differences. The media was changed every 3-4 
days.    
 
2.12. Experimental procedure  
 
2.12.1. Infection of murine primary cells  
Bone marrow-derived cells were taken and centrifuged for 5 min at 180 x g. The supernatant 
was discarded and the pellet was resuspended in 10 ml of fresh medium. The cells were 
counted in a "Neubauer" chamber and the concentration of cells was determined. The cells 
were adjusted to a final concentration of 1x10
6
 cells/ml in DMEM medium. Then the cells 
were seeded into a 4-well culture plate and incubated for 2h at 37°C and 5% CO2. After 2h 
the cells were infected with E. faecalis at a multiplicity of infection (MOI) of 10:1 for 
immunohistochemistry assays or microscopy. For killing assays a MOI of 1:1 was used. For 
electron microscopy a MOI of 25:1 was used. 
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2.12.2. Infection of HUVECs 
HUVECs were prepared as described in 2.11.3. The cells were counted in a "Neubauer" 
chamber and the concentrations of cells were determined. Cells were adjusted to a final 
concentration of 5x10
4
 cells/well in 500 µl culture medium and seeded into a 4-, 12- or 24-
well plate until a confluent monolayer was observed. Cells were washed twice with 1x PBS 
and fresh EBM-2 containing 5% FCS was added. The cells were infected with E. faecalis at a 
MOI of 10:1. For electron microscopy a MOI of 25:1 was used. 
 
2.12.3. Killing assay of intracellular enterococci by dendritic cells 
Dendritic cells were infected as described in 2.12.1 and incubated at 37°C, 5% CO2 and 95% 
humidity. After 2h antibiotics were added to samples. After 2h, 4h and 24h samples were 
taken, centrifuged at 180 x g for 10 min and lysed with 300 µL Triton-X100 for 5 min. 30 µL 
were taken and 20 µL were plated in a dilution series of 1:1, 1:2, 1:4, 1:8 and 1:16 of BEA-
agar plates. The plates were incubated at 37°C for 18 h and the CFU was counted. 
 
2.12.4. Killing assay of extracellular enterococci by mast cells 
Mast cells were infected as described in 2.12.1 and incubated at 37°C, 5% CO2 and 95% 
humidity. After 30, 60 and 180 min samples of 30 µL were taken and 20 µL were plated in a 
dilution series of 1:1, 1:2, 1:4, 1:8 and 1:16 of BEA-agar plates. The plates were incubated at 
37°C for 18 h and the CFU was determined. 
 
2.12.5. Mast cell extracellular traps killing 
To induce mast cells extracellular trap formation (MCET) mast cells were pre-treated with 10 
µg/ml PMA for 3 h. Subsequently, the cells were treated with 5 µg/ml cytochalasin D for 30 
minutes to inhibit cellular phagocytosis of cells that have not induced MCETs.  
Mast cells were infected as described in 2.12.1 with a MOI of 1:1 and incubated at 37°C, 5% 
CO2 and 95% humidity. After 30, 60 and 180 min samples of 50 µL were taken and plated in 
a dilution series of 1:1, 1:2, 1:4, 1:8 and 1:16 of BEA-agar plates. 
 
2.13. Microscopy 
 
2.13.1. Electron microscopy.  
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For scanning electron microscopy, samples were fixed with 5% formaldehyde and 2% 
glutaraldehyde in cacodylate buffer for 1 h on ice and washed in TE. Dehydration was 
performed with a graded series of acetone, critical-point dried with CO2, and sputter coated 
with gold before examination in a Zeiss field emission scanning electron microscope 
(DSM982 Gemini) at 5 kV using the Everhart-Thornley SE detector and the in-lens secondary 
electron (SE) detector in a 50:50 ratio.  
For transmission electron microscopy infected cells were washed twice with 0.1 M cacodylate 
buffer. Cells were fixed with 0.1 M cacodylate buffer + 5% paraformaldehyde + 2% 
glutaraldehyde and simultaneously contrasted with 1% aqueous osmium tetroxide for 1h at 
room temperature (RT). Afterwards, samples were washed with 0.1 M cacodylate buffer and 
dehydrated in a grade series of ethanol (10%, 30%, 50%, 70% and 90%) with 30 min on ice 
for each step. Following incubation with 100% ethanol for 30 min at RT, samples were 
embedded in Spurr resin (Spurr, 1969) and polymerized at 70°C f or 16 h. After 
polymerization ultra-thin section of infected cell layers were cut with a diamond knife. 
Sections were collected onto butvar-coated Cu-grids, contrasted with 4% uranyl-acetate 
(UAc) for 3 min at RT and lead-citrate for 15 sec at RT. Following a final washing step with 
ddH2O, sections were air dried and examined with a TEM EM 910. Images were recorded 
digitally with a Slow-Scan CCD-Camera (ProScan, 1024 x 1024) with ITEM-Software 
(Olympus Soft Imaging Solutions). Images were taken by Prof. Dr. M. Rohde (HZI 
Braunschweig).  
 
2.13.2. Double-immunofluorescence (DIF) microscopy 
500 µL eukaryotic cell suspensions (BMDC& BMMC: equal to 5x10
5
 cells/well; HUVEC: 
equal to 5x10
4
 cells/well) were added in a 4 or 24 culture well plate containing cover-slides. 
Murine cells were infected as described in 2.12.1 and HUVECs were infected as described in 
2.12.2. Cells were incubated at 37°C, 5% CO2 and 95% humidity. The cells were washed 
twice with 1x PBS and fixed with 3% PFA for 15 min at RT.  Then cells were washed twice 
with 1x PBS and blocked with 200 µL/well 1x PBS 10% FCS (h.i.) for 30 minutes. The 
blocking solution was discarded and 20 µL/well of a 20 µg/ml solution diluted in 1x PBS 
10% FCS (h.i.) of rabbit anti-E. faecalis antibody was added for further incubation for 30 
minutes at RT. After incubation the cells were washed twice with 1x PBS and the second 
antibody was added (20 µL/well of a 20 µg/ml solution diluted in 1x PBS 10% FCS (h.i.) of 
goat anti-rabbit IgG Alexa-Flour 488) and incubated for 30 min at RT. Then the cells were 
washed twice with 1x PBS and permeabilized using 200 µL 0.1% Triton-X 100 in 1x PBS per 
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well for 5 min at RT. In case of HUVECs an actin-staning with Alexa-Fluor 488 Phalloidin, 
20 µL/well of a 20 µg/ml solution diluted in 1x PBS 10% FCS (h.i.) for 30 min was 
performed. After two washing steps with 1x PBS, the third antibody was added (20 µL/well a 
20 µg/ml solution diluted in 1x PBS 10% FCS (h.i.) of rabbit anti-E. faecalis antibody) and 
incubated for 30 min at RT. The cells were washed twice again with 1x PBS and incubated 
with the last antibody (20 µL of a 5µg/ml solution of a goat anti-rabbit IgG Alexa-Flour 568 
antibody diluted in 1x PBS 10% FCS (h.i.)) for 30min at RT. The cells were washed twice 
with 1x PBS and the cover-slides were placed on a slide with 5 µL Moviol. After 1 h the 
cover-slides were sealed with nail polishing and used for microscopy. 
 
2.13.3. FITC-labeling of E. faecalis 
E. faecalis inoculum was cultured as described under 2.10.1. Carboxyflourescein was added 
to bacteria suspension in a concentration of 0.2 mg/ml and incubated for 30 min at 4°C in the 
dark. Then, the cultures were centrifuged at 1,900 x g for 10 min and washed in 1x PBS until 
the supernatant was colorless. 
 
2.13.4. LIVE/DEAD stain 
250 µL mast cells (2,5x10
5
 cells/well) were added in a culture well plate, which contained a 
poly-l-lysine treated cover-slide. Mast cells were infected as described under 2.12.1 and 
incubated at 37°C, 5% CO2 and 95% humidity. The cells were washed twice with 1x PBS.  
500 µL fresh DMEM medium was added. 5 µL each of the two compounds of LIVE/DEAD
ʀ 
BacLight
TM 
Bacterial/Viability Kit (INVITROGEN) were mixed 1:2. 2 µL of the mixed 
staining solution was added to each sample and incubated for 15 min at RT. After incubation 
the samples were washed in 1x PBS and the cover-slides were placed on a slide with 5 µL 
Moviol. After 2h the cover-slides were sealed with nail polishing and used for microscopy 
 
2.13.5. Toluidine stain 
250 µL of mast cells (5x10
5
 cells/well) were infected as described in 2.12.1 and incubated at 
37°C, 5% CO2 and 95% humidity. After 2h the mast cells were fixed with 3% PFA for 10 min 
at RT. 100 µL of cell suspension was centrifuged on slides at 150 x g for 5 min and dried on 
air at RT. 5 µL of Toluidine-blue (0.5% in 1x PBS) was spotted on the slides and incubated 
for 5 min at RT. Subsequently, the slides were washed with water until the blue color 
disappeared.   
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2.14. Immunohistochemistry 
 
2.14.1. Measuring Mast Cell Mediator Release (β-Hexosaminidase) 
 
Mast cells were resuspended in the TYRODES buffer and aliquoted into 96-well plates 
(BMMCs 90.000/well) in a final volume of 100 µL. Cells were incubated in 37 °C for 5–10 
min to equilibrate the cells to the activation temperature.  
10× stocks of agonists or inhibitors (antagonists) were prepared in TYRODES buffer. 10 μL 
of these stocks were added to each well. The plate was incubated in a heating block or warm 
air oven at 37 °C for 30 min (without CO2). 100 μL of PNAG solution was transferred into 
two new 96-well plates using a multichannel pipette. One plate is for measurement of secreted 
β-hexosaminidase activity (supernatants) and the other is used to calculate the total amount of 
supernatants and lysates to determine the percentage release. After incubation, the plate was 
centrifuged at 450 x g, at 4 °C for 5 min to stop the reaction and to ensure the cells are 
sediment to the bottom of the wells. The plate was tilt to an angle of 45° and carefully 50 μL 
aliquots of the cell-free supernatant was removed from the top using a multichannel pipette 
where the depth of the solution is greatest. The aliquots were added into the PNAG solution 
and the plate was incubated for 90 min at 37 °C (without CO2). It is important that the cells 
are not transferred into PNAG solution. In order to calculate the total β-hexosaminidase 
activities, add 150 μL of 0.1% Triton X-100 solution into the 50 μL of supernatants and cells 
remaining in the original incubation plate. Resuspend carefully and take 50 μL of lysates and 
add into the PNAG solution and incubate the plate for 90 min at 37 °C (without CO2). After 
incubation, add 50 μL 0.4 M Glycine buffer into each well. The appearance of yellow color 
indicates the extent of β-hexosaminidase activity. Read plate absorbance at 405 nm with 
reference filter at 620 nm. Calculate the percentage of hexosaminidase activities present in the 
supernatants. The protocol is adapted and modified from [156]. 
 
2.14.2. ELISA 
The concentration of different cytokines and chemokines was determined by using 
commercial ELISA systems (BD Pharmingen). For this purpose, a 96-well plate was coated 
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with the respective anti-mouse antibody for TNF-α; IFN-γ & IL-6 diluted 1:250 in 0.1M 
Na2HCO3 or MCP-1 & IL-12p70 1:250 in 0.2M Na2PO4 or KC & MIP2 1:180 in 1x PBS at 
4°C overnight which is different to the manufactures manual. To detect cytokines and 
chemokines from human cells, anti-human antibody for IL-1β and IL-8 were diluted 1:250 in 
0.1M Na2HCO3 at 4°C overnight which is different to the manufactures manual. The wells 
were washed three times with 0.05% Tween in 1x PBS (PBST) and blocked with 10% FCS-
PBS for 1h. Then, the wells were washed again with PBST and samples and standards were 
added for 2h. After incubation for 2h, the wells were washed again and a biotinylated anti-
mouse or anti-human antibody was added as detection antibody 1:250 in 10% FCS-PBS 
followed by incubation for 1h. After washing with PBST streptavidin-peroxidase 1:250 in 
10% FCS-PBS was added for 30 min at RT. After the final PBST washing step, the ELISA 
was developed using 50 µL TMB per well. To stop the reaction 25 µL of 2N sulfuric acid was 
added. A standard curve was plotted for each cytokine using the corresponding recombinant 
protein as standard. The concentration was calculated based on the generated standard curve 
measuring the absorption at 450 nm against a reference wavelength at 570 nm (TECAN 
Sunrise). 
 
2.14.3. Flow cytometry 
To determine the purity of a cell culture, flow cytometry analysis was used. Briefly, 200 μL of 
the cell culture sample was taken from a culture, and the FcγIII/II receptors were blocked with 
0.25 µg/ml mouse anti-FcγIII/II antibody for 5 min at RT. To stain the CD117 c-kit receptor 
on the mast cell surface or the CD11c receptor on the surface of DCs, the cell suspension was 
incubated with 2µg/ml of anti-CD117 c-kit antibody or anti-CD11c antibody for 1 h at 4°C. 
After incubation, the cells were washed with 2.5 ml 10% FCS (h.i.) in 1x PBS and centrifuged 
at 180 x g for 5 min. Dendritic cells infected as described in 2.12.1 were also measured for 
CD40; CD80 and CD86. Dendritic cells were double-stained with anti-mouse CD11c-PE 
antibody and one additional surface marker (2µg/ml in DMEM for 1h at 4°C). HUVECs 
infected as described in 2.12.2 were measured for CD54, CD62-E and CD106. HUVECs were 
only single stained with 2 µg/ml of anti-CD54, anti-CD62-E and anti-CD106 antibody for 1h 
in EBM-2 at 4°C. The supernatant was discarded and the sample was measured with a BD 
Calibur or BD LSR II (BD BIOSCIENCE). An unstained sample was used as negative cell 
population. 
 
2.15. Molecular biology methods 
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2.15.1. Agarose gel electrophoresis 
DNA fragments were separated by agarose gel electrophoresis in an electric field. Unless 
otherwise specified, the separation was carried out in a 1% agarose gel (in TAE buffer) at  
100 V and 500 mA for 45 min. Afterwards, the gel was stained in a 0.001% ethidium bromide 
solution for 10 min. Gene Ruler DNA Ladder Mix (FERMENTAS) was used as a size 
standard. 
 
2.15.2. cDNA synthesis 
cDNA was synthesized by using the High Capacity cDNA Reverse-Transcription-Kit 
(APPLIED BIOSYSTEMS). Each step was performed on ice or at 4°C. Briefly, 1 µL RNA 
(1-3µg) were incubated with 2 µL Oligo(dT)15 and 10 µL DEPC-water at 70°C for 10 min 
and further for 2 min on ice.  8 µL master mix was added (4 µL 5xFirst strand-Puffer; 2 µL 
100mM DTT; 1 µL 10mM dNTPs; 0.4 µL Rnasin; 0.6 µL DEPC-water) and incubated for 2 
min at 42°C. After 2 min 1 µL reverse transcriptase was added and further incubated for 30 
min. 10 µL TE buffer were added and the samples were incubated for 2 min at 90°C and then 
stored on ice. For long-term storage samples were kept at -80°C. 
 
2.15.3. Quantitative Real Time Polymerase Chain Reaction (qRT-PCR) 
 
2.15.3.1. Preparation   
Murine primary cells were infected as described in 2.12.1. Human cells were infected as 
described in 2.12.2. Samples were taken after 6 h and 24h, non-infected cells served as 
controls. For qRT-PCR, β-actin was used as housekeeping gene and internal control for 
normalization of the cDNA amount. cDNA was analyzed for differential gene expression. The 
used primers are listed in Table 3 for mouse genes and Table 4 for human genes. The reaction 
mixture was prepared with the SensiFAST™ SYBR & Fluorescein One-Step Kit (BIOLINE) 
as shown in table 8. 
 
 
Table 7. qRT-PCR reaction mixture 
qRT-PCR--Master mix µl Final concentration Reduced approach [µl] 
2x SensiFAST Mix 10 1x 6.25 
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qRT-PCR--Master mix µl Final concentration Reduced approach [µl] 
10µM F-Primer 0.8 400nM 0.5 
10µM R-Primer 0.8 400nM 0.5 
RT 0.2   0.125 
RiboSafe RNase Inhibitor 0.4   0.25 
Water (DEPC) 3.8   2.375 
Template 4   2.5 
Total volume 20   10 
 
The RT reaction was performed on a Rotor-Gene Q (QIAGEN).  
 
Table 8. Cycling program 
2-Step Cycling program 
1x 45°C 15min.  for RT 
1x 95°C 5min. activation of polymerase 
40x 95°C 20sec denaturation 
...  °C 20sec annealing 
72°C 20sec extension 
1x 55 – 92 °C ∞ melting 
 
2.15.3.2. Analyze of qRT-PCR  
The data was calculated using 2
-ΔΔCT
 of the Pfaffl equation [157] and expressed as a ratio of 
the relative mRNA expression in infected samples compared to the uninfected controls.  
 
2.15.4. RNA Extraction  
For infections, 1x10
6
 murine cells in 1 ml DMEM medium were infected as described in 
2.12.1. For human cells, 1x10
5
 cells in 1 ml  EBM-2 medium were infected as described in 
2.12.2.. After 6 h and 24h, the cells were collected by centrifugation (180 x g, 10min, RT) and 
the supernatant was discarded. The cell pellet was washed in 1x PBS and centrifuged again. 
The supernatant was discarded and the pellet resuspended in 350 µL RLT buffer 
supplemented with 10 µL β-mercaptoethanol. The RNA extraction was performed by using 
the RNeasy Mini Kit (QIAGEN) according to the manufacturer´s instructions. Total RNA was 
isolated so prokaryotic and eukaryotic RNA could be detected. Afterwards a DNase treatment 
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(AMBION) was done according to the manufacturer´s instructions to completely remove 
DNA.  
 
 
 
 
2.16. Experiments with mice 
 
2.16.1. Animal husbandry of mice 
8 weeks-old female C57BL/6 mice or Balb/c were purchased from Harlan-Winkelmann 
(Borchen, Germany). Mice were housed in microisolator cages and were given food and water 
ad libitum. All experiments were performed in accordance with protocols approved by the 
local animal ethical committee board. 
 
2.16.2. Euthanasia of mice 
The mice were killed painlessly by gassing with carbon dioxide. 
 
2.16.3. Intraperitoneal (IP) infection in mice 
For intraperitoneal infection a mouse was placed on the cage lid and fixed in the neck. The 
animals were maintained with the head down during the infection, in order to relieve the 
abdominal cavity. The cannula (0.45 x 12mmB, Braun) was introduced approximately 1 cm in 
the lateral abdominal and 500 μL of a 5x108 bacterial suspension was injected into the 
peritoneal cavity.  
 
2.16.4. Peritoneal lavage  
At different time points post infection the mice were killed as described in 2.16.2. The 
abdominal cavity was washed twice with exactly 5 ml of DMEM medium, removed and 
transferred to a Falcon tube. Cells collected during lavage were centrifuged at 180 x g and 
4°C for 5 min. The cells were counted and stained for flow-cytometry as described in 2.14.3. 
The samples were analyzed with FLOWJO v7.6.5. 
 
2.17. Statistical analysis 
All experiments were done at least three times unless otherwise stated. A comparison between 
groups was performed by using GraphPad Prism 5.0 with one-way Anova non-parametric 
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Friedman test or Wilcoxon test. P-values less than 0.05 were considered to be statistically 
significant. 
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3. Results 
3.1 Characterization of virulence-associated genes in Enterococcus faecalis 
strains from different clinical disease manifestations 
The reasons for the change in epidemiology and clinical manifestation of enterococcal-
associated diseases as well as the increasing role of these microorganisms as a source of 
nosocomial infections still remain unknown. Whether this rise in the incidence of severe 
enterococcal infections resulted from changes in virulence properties of the bacteria and/or 
increased host susceptibility to factors produced by reemerging enterococcal strains due to the 
lack of protective immunity remains an active area of research. These possibilities are not 
mutually exclusive, and there is little doubt that the disease outcome is determined by host-
pathogen interplay.  
E. faecalis is able to cause a variety of different diseases ranging from urinary tract, wound to 
soft tissue infections as well as sepsis and endocarditis [19-21]. To investigate if the presence 
of certain virulence factors is correlating with disease manifestation, the presence of certain 
virulence genes in various isolates representing different disease outcomes have been 
investigated. Five strains were collected from patients that developed endocarditis: six strains 
from patients with infections resulting from artificial hip joint transplantation and eight strains 
from patients with serious blood infections as well as one case of bone infection caused by E. 
faecalis have been used for this study.  
No specific correlation between the presence of virulence genes and disease manifestation 
could be determined (see table 10, appendix). The abundance of virulence genes in all 
investigated strains showed only moderate differences among the different strains. These 
findings argue for either the influence of the regulation of the expression of virulence factors 
on one side but also for an influence of host immune factors, which are involved in disease 
manifestation, progression and resolution of infections caused by this opportunistic pathogen 
on the other side. This finding strengthens the importance to investigate the influence of host 
immune mechanisms in the pathogenesis of E. faecalis induced infections.    
 
3.2. Response of mast cells (MCs) during infection with E. faecalis 
One important aim of this study was first to characterize the role of MCs, an innate immune 
cell population abundantly present beneath the intestinal mucosal barrier, in response to E. 
faecalis and second the specific aspects of the signaling pathways involved in this response. 
The role of TLR2-MyD88 signaling pathway, one of the most important signaling pathways 
 45 
 
for immune recognition of Gram-positive was explored for MCs to E faecalis infection. A 
central finding was that MCs can contribute significantly by extracellular killing mechanisms 
to the control of E. faecalis. In addition, the response of MCs to E. faecalis includes 
degranulation and release of inflammatory cytokines dependent on TLR2-MyD88 signaling. 
 
3.2.1. E. faecalis shows a strong association to the surface of MCs in vitro and is able to 
induce MC degranulation 
One of the extracellular interactions between MCs and E. faecalis consist in the extracellular 
bacterial association of the bacteria to the surface of MCs (FIG 3.1. A). Furthermore, electron 
microscopic investigations reveal a strong induction of MC degranulation in response to E. 
faecalis characterized by a rapid release of pre-stored granules into the extracellular 
environment (FIG 3.1. B).  
 
 
 
FIG 3.1.: Interaction of E. faecalis with MCs. (A) Association of E. faecalis on the surface of 
MCs 2h post infection indicated by white arrows. (B) MCs degranulation in response to E. 
faecalis. Release of granules is indicated by white arrows. Bar represents (A) 1µm, (B) 2µm. SEM 
images by Prof. Dr. Manfred Rohde, Helmholtz Center for Infection Research.  
 
 
3.2.2. MCs are able to limit the bacterial growth of E. faecalis 
As MCs have been previously shown to inhibit the growth of several important human 
pathogens [90, 97], it was determined if MCs were also capable to modulate the growth of E. 
faecalis in vitro. For this purpose, the growth of E. faecalis was determined over time in the 
presence and absence of MCs. The results depicted in Fig. 3.2 A. show that MCs were also 
very efficient to suppress the growth of E. faecalis. MCs were capable to inhibit the growth 
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over a wide range of clinical isolates and no correlation between growth inhibition and 
clinical presentation could be found (Fig. 3.2. B). 
 
 
 
FIG 3.2.: Growth inhibition of E. faecalis by MCs. (A) MCs were infected as described in section 
2.12.1 with E. faecalis strain OG1RF over a 90 min time course. After 30, 60 and 90 min the CFU 
was determinate by plating serial dilutions on bile-esculin agar plates and compared against a 
growth control of bacteria without MCs. (B) Growth inhibition of different clinical isolates in 
percent using the following formula: [(CFU in medium alone - CFU in medium with MCs) / CFU 
in medium alone]*100. Each bar represents the mean SD of triplicates from three independent 
experiments. ***, P < 0.001. 
 
 
3.2.3. MCs contribute to the growth inhibition of E. faecalis by various extracellular 
mechanisms 
It has previously been shown that growth inhibition elicited by MCs in response to bacterial 
pathogens is mediated by the release of MCETs that are antimicrobial [97]. The release of 
MCETs upon encounter of E. faecalis was determined. For this purpose, MCs were infected 
for 3h with E. faecalis, fixed, and processed for immunofluorescence microscopy using 
bacterial Live/Dead
®
 staining. Live bacteria appear in green and dead bacteria in red. The 
MCETs were counterstained with the DNA dye DAPI as DNA is the backbone of MCETs. It 
could be clearly shown that MCs release MCETs in response to E. faecalis (FIG. 3.3. A). 
Interestingly, many bacteria that were trapped within MCET structures appeared green and 
seem to be alive (FIG 3.3. A and B). In addition, bacteria that were not in contact with these 
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structures appear red. This finding gives evidence that a second mechanism is responsible for 
direct killing of E. faecalis by MCs.      
To determine the proportional contribution of MCETs to the growth inhibition of E. faecalis, 
MCs were infected with E. faecalis at a MOI of 1:1 for 60 min in the presence or absence of 
50 mU endonuclease to degrade the DNA backbone of MCETs [97]. This digestion of 
MCETs resulted in only partial growth inhibition of E. faecalis by MCs suggesting that also 
degranulation contributes to killing of E. faecalis (FIG 3.3. C). To confirm this postulation, 
the levels of growth inhibition of E. faecalis by MCs was determined in degranulated 
(cromolyn-treated) MCs and MCs, in which MCETs have been dismantled by nuclease 
treatment. MCs treated with both - cromolyn and nuclease - were completely impaired in their 
capacity to inhibit the growth of E. faecalis (FIG 3.3. C). These results confirmed the 
contribution of both the release of MCETs and release of granules to the antimicrobial effect 
of MCs against E. faecalis. 
 
 
 
FIG. 3.3.:  Live/Dead
®
 staining of MCs infected with E. faecalis at an MOI of  10:1. (A and B) 
Immunofluorescence microscopic overview of mast cells releasing MCET in response to E. 
faecalis. Dead bacteria (red color) as well as live bacteria (green color), could be found in 
association with MCETs (blue color). (B) Magnification of area in (A) indicated by arrows. (C) 
Growth of E. faecalis in medium alone or co-cultured with MCs either untreated or treated with 
cromolyn (to block degranulation), nuclease (to dismantle MCET structures) or both for 90 min. 
Each point represents the mean ± SD of triplicates from three independent experiments. ***, p < 
0.0001 
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3.2.4. Role of TLR2-MyD88 signaling pathway in immune response of MCs to E. faecalis 
 
3.2.4.1. Release of MCETs is not depending on the TLR2-MyD88-signaling pathway  
Immunofluorescence microscopy was performed to examine if and to which extent TLR 
signaling is involved in the formation of MCETs after encounter of E. faecalis. MCs derived 
from wild type, TLR2 
-/- 
and MyD88 
-/-
 mice were infected with E. faecalis at an MOI of 1:1 
for 3h and extracellular traps were stained by DAPI. The number of MCETs per cell has then 
been counted microscopically in ten independent fields of view. No differences in the 
formation of MCETs were observed among the different knock out cells compared to the 
wild-type cells demonstrating that TLR/MyD88 signaling is not involved in this particular 
extracellular response of MCs towards E. faecalis.    
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FIG 3.4.: Release of MCET is TLR-MyD88-pathway independent. Numbers of MCETs released 
during in vitro infection with E. faecalis were counted in ten independent fields of view. No 
significant difference between wild-type, TLR2 
-/-
 or MyD88 
-/-
 MCs could be obtained. Each bar 
represents the mean ± SD of microscopical counts of ten independent fields of views. ***, P < 
0.001. 
 
 
3.2.4.2. TLR2 signaling is crucial for cytokine response of MCs after recognition of E. 
faecalis  
 
To investigate the cytokine response of MCs to E. faecalis, the release of IL-6 and TNF-α of 
MCs derived from wild-type or mice deficient in TLR2 or MyD88 was measured by ELISA. 
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In an in vitro infection it could be demonstrated that the amount of IL-6 and TNF-α is 
significantly lower in MCs derived from MyD88 knockout mice than those derived from MCs 
of wild-type origin (FIG.3.5.).  
 
 
FIG 3.5.: Cytokine profile of MCs derived from wild-type TLR2 
-/-
 or MyD88 
-/-
 mice in response 
to E. faecalis. MCs derived from wild-type TLR2 
-/-
 or MyD88 
-/-
 mice response with a lower 
release of IL-6 (A) and TNF-α compared to cells derived from wild-type mice (24h post-
infection). Each bar represents the mean ± SD of three independent experiments. **, P < 0.01. 
 
 
To further demonstrate that this release is mainly TLR2 signaling dependent, TLR2 
-/-
 MCs 
were infected with E. faecalis in vitro. As shown in FIG 3.5. the level of TNF-α and IL-6 
released by TLR2 
-/-
 MCs is significantly lower than the levels released by MCs from wild-
type mice. The fact that the amount of cytokines released by TLR2 
-/- 
cells is comparable to 
the amount released by MyD88 
-/-
 cells argues for a central role of the TLR2 signaling 
pathway in the release of inflammatory cytokines by MCs in response to enterococci.  
 
3.2.4.3. TLR2 signaling is essential for MC degranulation during E. faecalis infection 
MC degranulation has been shown to be of critical importance for the antimicrobial properties 
of MCs to E. faecalis. To explore the contribution of TLR2 signaling in the recognition of E. 
faecalis by MCs, the degranulation response of MCs derived from mice deficient in the 
adaptor molecule MyD88 and mice deficient in the surface receptor TLR2 were studied in an 
in vitro infection with E. faecalis. MyD88 
-/-
 as well as TLR2 
-/-
 MCs showed a significantly 
lower potential in their ability to degranulate in response to E. faecalis, demonstrated by 
measuring the release of β-hexosaminidase – a lysosomal enzyme released by MCs which is 
used as a marker for degranulation [156] – in FIG 3.6. (A) in comparison to the corresponding 
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wild-type cells. This finding indicates once more the importance of the TLR/MyD88 signaling 
pathway in the recognition and global immune response of MCs towards this microorganism.  
 
 
 
FIG 3.6.: TLR2 signaling is important for degranulation and control of E. faecalis growth. MCs 
derived from wild-type TLR2 
-/-
 or MyD88 
-/-
 mice have a lower ability to degranulate (A) and 
therefore to inhibit bacterial growth of E. faecalis (120 min post-infection) (B). Each bar 
represents the mean SD of quadruplicates from two independent experiments. *, P < 0.05; **, P < 
0.01.; ***, P < 0.001. 
 
 
Extracellular killing of enterococci by MCs are of central importance in immune defense of 
MCs against enterococci [158]. To determine the impact of TLR2-MyD88 signaling to the 
control of bacterial growth, MCs derived from MyD88 
-/-
 and TLR2 
-/-
 mice were infected in 
vitro with E. faecalis as described in section 2.12.1 and compared with MCs derived from 
wild-type mice. As depicted in FIG 3.6 (B) TLR2 
-/-
 and MyD88 
-/- 
MCs showed reduced 
degranulation that translates into reduced inhibition of the bacterial growth. These findings 
demonstrate the central importance of the TLR/MyD88 pathway in the immune response of 
MCs to E. faecalis.  
 
3.2.5. Morphological change on bacterial surface of E. faecalis during co-cultivation with 
MCs 
E. faecalis co-cultivated with supernatant of wild-type mast cells showed morphological 
surface changes (FIG 3.7. A and D). The formation of these vesicle-like structures on the 
C 
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surface of E. faecalis was diminished by co-cultivated with supernatant from TLR2 
-/-
 MCs 
(FIG 3.7. B) or medium control (C).  
 
FIG 3.7.: SEM images of E. faecalis co-cultivated with either wild-type MCs (A and D), TLR2 
-/-
 
MCs (B), or medium alone (C) (white arrows indicate membrane vesicle formation in the surface 
of E. faecalis). Bar (A-C) represent 1µm, (D) 200nm. (SEM images by Prof. Dr. Manfred Rohde, 
Helmholtz-Centre for Infection Research).  
 
 
3.2.6. Cathelicidin LL-37 released by MCs in response to enterococci exhibits strong 
antimicrobial effects against these bacteria 
MCs are able to release a variety of different components by degranulation [159]. One of 
these components is the cathelicidin LL-37, which is pre-stored in granules and immediately 
released after contact with degranulation-inducing stimuli. This antimicrobial peptide elicits a 
strong direct antimicrobial effect on Gram-positive bacteria [98, 99]. To investigate whether 
LL-37 is also of central importance in the ability of MCs to control bacterial growth of E. 
faecalis, the bacteria were treated with different concentrations of recombinant LL-37.  
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FIG 3.8.: LL-37 shows a potent antimicrobial effect on E. faecalis. (A) Different concentrations of 
LL-37 were added to a bacteria culture for 120 min and the bacterial growth was measured and 
compared to a medium control. 10 µg/ml LL-37 shows a significant higher bacterial growth 
inhibition compared to the control. The effect of LL-37 is dose-dependent. Each bar represents the 
mean ± SD of quadruplicates from independent experiments. *P <0.05. (C) Vesicle-like structures 
were observed when bacteria were treated with 10 µg/ml LL-37. These structures show a similar 
morphology compared to the membrane structures that have been observed when E. faecalis is co-
cultured with wild-type MCs. Bacteria cultivated in medium alone serves as negative controls (B); 
bar represent 1µm. SEM images by Prof. Dr. Manfred Rohde, Helmholtz-Centre for Infection 
Research. 
 
 
As demonstrated in FIG 3.8., LL-37 showed a potent dose-dependent antimicrobial effect 
against E. faecalis. Another interesting finding is that E. faecalis bacteria incubated in the 
presence of 10 µg/ml LL-37 showed similar surface associated vesicle-like modifications 
compared to bacteria that have been incubated within the supernatant of degranulated wild-
type MCs (FIG 3.8. C and E). This finding reveals a potential role for LL-37 in the membrane 
destabilization processes, leading to bactericidal or bacteriostatic properties. Therefore, LL-37 
is an essential antimicrobial component released during degranulation by MCs in response to 
these microorganisms.  
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3.3. Role of dendritic cells in E. faecalis infections 
 
3.3.1. DCs are among the first immune cell populations entering the site of enterococcal 
infections 
Dendritic cells are part of the first line of the innate immune defense against invading 
pathogens. DCs were found on sides that are exposed to the environment similar to 
macrophages or mast cells making them prime sentinels [103] for the recognition of microbial 
agents.  
After recognizing microbes, DCs undergo a process called maturation. This process is 
characterized by upregulation of costimulatory markers and the release of inflammatory 
cytokines and chemokines [104]. Studies, which examine the interaction of enterococci with 
DCs, are very rare and their interaction with DCs is not intensively studied, even though DCs 
are important contributors of the innate immune response towards pathogenic bacteria. 
The potential importance of DCs in the immune defense to E. faecalis is indicated by an 
intraperitoneal infection model of E. faecalis where DCs are among those innate immune cell 
types that significantly increased in number. The number of different invading immune cells 
was obtained by flow cytometry in mice, infected intraperitoneally with 5*10
8
 CFU of E. 
faecalis as described in 2.16.4. 
Intraperitoneal infection of Balb/c mice with 5x10
8
 CFU of E. faecalis results in a massive 
increase of various immune cells like PMNs, macrophages and even MCs (FIG. 3.9. B-D). 
Interestingly, a marked and highly significant increase in the number of DCs could be 
observed following infection by E. faecalis compared to uninfected control mice (FIG. 3.9. 
A). These data suggest that DCs play an important role in coordination of host immune 
response towards enterococci.  
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FIG 3.9.: Cellular response in the peritoneal cavity of Balb/c mice intraperitoneally infected with 
5*10
8
 CFU of E. faecalis. Depicted is the infiltration of DCs (A), MCs (B), macrophages (C) and 
PMNs (D) into the peritoneal cavity of E. faecalis infected mice, 3h post infection (p.i.). Each bar 
represents the mean ± SD of five mice. *, P < 0.05; **, P < 0.01.; ***, P < 0.001. 
 
 
3.3.2. E. faecalis is associated with DCs in vivo 
To examine whether enterococci are associated with DCs in vivo, mice were injected 
intraperitoneally with 5x10
8
 CFU of GFP-expressing E. faecalis OG1RF bacteria or PBS as a 
control, and peritoneal washes were collected after 30 min. Peritoneal cells were stained with 
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PE-conjugated anti-CD11c antibodies and the proportion of CD11c
high
 GFP positive cells 
were analyzed by flow cytometry. As shown in FIG 3.9. upon administration with 5x10
8
 
CFU, 20±4,1% of DCs were associated with GFP-expressing E. faecalis, the mean fluorescent 
intensity (MFI) increased from 478 (uninfected DCs) to 10567 (FIG 3.11.).  
 
 
 
 
FIG 3.10.: Fluorescence panels showing co-localization of DCs and a GFP-expressing E. faecalis 
strain in vivo. The cells were collected as described in 2.16.4, counted and stained for flow-
cytometry described in 2.14.3. (A) shows a quadrant-analyzation of DCs (PE 
+
) in a non-infected 
control (lower right quadrant). (B) shows the DCs (PE 
+
) colocalized with  GFP-expressing E. 
faecalis (FITC
+
) (upper right quadrant). (C) shows the MFI a histogram of CD11c of DCs infected 
with GFP-expressing E. faecalis (red) and the MFI of DCs (light blue) in a non-infected setting in 
PE channel. (D) shows a histogram of the DCs when DCs were colocalized with E. faecalis in red 
and in light blue the non-infected DCs in the FITC detection channel.  
 
 
These data reveal a strong association of E. faecalis with DCs in vivo (FIG 3.10) underlining 
the importance of these cells in host innate immune response to enterococci. Methods applied 
are described in section 2.16.3.; 2.16.4. and 2.14.3.  
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FIG 3.11.: Co-localization of DCs with E. faecalis. The increase in the GFP signal intensity 
indicates co-localization of DCs and GFP-expressing E. faecalis in vivo. 
 
 
3.3.3. E. faecalis–induced expression of maturation markers on immature DCs 
To investigate the ability of E. faecalis to induce DCs maturation, expression of maturation 
markers CD40, CD80 and CD86 on the cell surface were determined in DCs 24h after 
infection with E. faecalis by flow cytometry as described in section 2.14.3. The expression on 
unstimulated cells served as negative controls and stimulation with heat-killed E. faecalis 
bacteria were used as positive controls. The release of IL-12p70 after 24h post infection was 
also measured. DCs were infected as described in section 2.12.1 and the amount of cytokines 
released into the cellular supernatant was determined by ELISA as described in section 
2.14.2. The results shown in FIG 3.12 indicate that infection with E. faecalis leads to efficient 
DC maturation as determined by upregulation of the surface marker CD40, CD80 and CD86 
as well as the release of IL-12p70 during infection. 
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FIG 3.12.: Maturation of DCs after infection with E. faecalis. Maturation was determined by the 
upregulation of costimulatory proteins on the cellular surface of DCs. During in vitro infection of 
DCs with E. faecalis significantly higher levels of CD40, CD80 and CD86 are expressed on the 
cellular surface compared to a non-infected control (A and C). Furthermore the amount of IL-
12p70 – the active form of IL-12 – is significantly higher compared to the levels released by non–
infected control cells (D). One representative experiment out of four is shown. **, P < 0.01.; ***, 
P < 0.001. 
 
 
3.3.4. DCs encountering E. faecalis elicit an inflammatory cytokine milieu 
Next, it was examined which cytokines were released by DCs upon infection with E. faecalis. 
Bone marrow-derived DCs were infected as described in 2.12.1. Important immune regulatory 
effectors released by DCs are cytokines and chemokines involved in the modulation of the 
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humoral and cellular inflammatory response; therefore, the released levels of IFN-γ as well as 
the chemoattractant proteins KC and MIP2 were analyzed in the cellular supernatant of E. 
faecalis infected DCs.  
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FIG 3.13.: Cytokine milieu of E. faecalis infected DCs. The release of proinflammatory cytokines 
und chemokines by DCs is increasing during infection with E. faecalis. Besides the potent 
immunomodulatory cytokine IFN-γ (A) the chemotactic active molecules KC (B) responsible for 
PMN recruitment to the site of infection and MIP2 (C) responsible for the recruitment of 
macrophages are induced by E. faecalis in DCs. Each bar represents the mean ± SD of five 
independent experiments.  *, P < 0.05; ***, P < 0.001. 
 
 
The results, shown in FIG 3.13., indicate that DCs release several cytokines such as KC (B) 
and MIP2 (C) with immunomodulatory function in response to infections with E. faecalis, 
which have important chemotactic properties for the recruitment of phagocytic active cells to 
the site of infection, like PMNs and macrophages. These cells are additionally activated by 
IFN-γ, supporting a potential role of DCs in the coordination of phagocyte recruitment and 
activation during enterococcal infections. 
 
3.3.5. In vitro phagocytosis of E. faecalis by bone marrow-derived dendritic cells 
(BMDC) 
To determine the ability of DCs to phagocytize E. faecalis during in vitro infection, cells were 
infected with E. faecalis at an MOI of 10:1 as descript under 2.12.1. Briefly, after 2h the 
remaining extracellular bacteria were killed by incubation in the presence of 100 µg/ml of 
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gentamicin. At indicated time points, cells were washed twice with sterile PBS and lysed with 
0.1% Triton X-100 in PBS. The number of viable bacteria was determined by serial dilutions 
plated on bile esculin agar plates.  
The CFU enumeration showed that the number of surviving intracellular bacteria is 
significantly diminished over time; at 24h post infection nearly no viable intracellular bacteria 
are detectable (FIG 3.14.). 
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FIG 3.14.: Intracellular killing abilities of DCs against E. faecalis. DCs were infected as described 
in 2.12.1.  Level of viable intracellular bacteria at 6 h and 24h post infection demonstrating an 
efficient killing of E. faecalis within DCs. ***, P < 0.001. 
 
 
To confirm the killing of E. faecalis within DCs, fluorescence microscopy (FIG 3.15.) and 
transmission electron microscopy (FIG 3.16.) were applied. For double immune fluorescence 
studies, extracellular bacteria were labeled green and intracellular bacteria were labeled red. 
As shown in FIG 3.15. most of the microorganisms displayed red fluorescence, indicating that 
E. faecalis was very efficiently internalized by DCs. 
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FIG 3.15.: Double-immunofluorescence image of DCs infected with E. faecalis. (A-B) non-
infected DCs were stained as described in section 2.13.2. (C) DCs were infected with an MOI of 
10:1 for 6h. Extracellular bacteria appear in yellow (merged channels of green and red) and 
intracellular in red. (D) Magnification of section (C). (E) DCs were infected with an MOI 10:1 of 
bacteria for 24h. (F) Magnification of section (E). Extracellular bacteria appear in yellow and 
 61 
 
intracellular in red. Arrows mark intracellular bacteria. Bar represents (A-C; E) 10µm and (D; F) 
1µm. 
Transmission electron microscopic examination of in vitro-infected DCs revealed the 
presence of E. faecalis bacteria associated with and in the process of being phagocytosed by 
DCs (FIG 3.16. (B and D). Ultrathin sections of infected DCs displayed in FIG 3.16. revealed 
that E. faecalis resides intracellularly within phagosomes, where the bacteria undergo 
progressive degradation. FIG 3.16. shows that the degradation process of enterococci starts 
with the detachment of the capsule from the bacterial cell wall and the degradation of capsular 
material (indicated by white arrows in FIG 3.16. C).  
 
 
FIG 3.16.: Phagocytotic activities of DCs during infection with E. faecalis. DCs were infected as 
described in 2.12.1. The TEM images show (A) non-infected control cells and (B-D) phagocytic 
uptake of E. faecalis by DCs. Bar represent 2 µm (A-B), 1 µm (C) and 500 nm (D). TEM images 
were taken by Prof. Dr. Manfred Rohde, Helmholtz-Center for Infection Research. 
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3.3.6. E. faecalis is located and killed in lysosome-associated-membrane-protein-1 
(LAMP-1) positive compartments within DCs 
To gain further insights into the intracellular localization of ingested E. faecalis, it was 
investigated if ingested bacteria are localized within phagolysosome compartments using the 
marker LAMP-1. Therefore a LAMP-1 staining was performed using an Alexa568 conjugated 
anti-Lamp-1 antibody and a GFP-expressing E. faecalis strain (s. 2.13.2). FIG 3.17. (A) 
shows a non-infected control. FIG 3.17. (B) as well as the magnification of it in (C) show the 
co-localization of the GFP-expressing bacteria and the red LAMP-1 signal demonstrate the 
intracellular localization E. faecalis within LAMP-1 positive compartments. This observation 
is underlining a potent and highly efficient killing ability of DCs via lysosomal degradation of 
E. faecalis. 
 
 
 
 
FIG 3.17.:  E. faecalis is contained in LAMP-1 positive compartments within DCs. The 
immunofluorescence images of LAMP-1 positive compartments (red) show a co-localization with 
a GFP-expressing strain of E. faecalis (green), colocalized bacteria appear in yellow. (A) Non-
infected control cells; (B) infection with a GFP-expressing strain of E. faecalis; (C) magnification 
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of (B). The DNA in the nucleus is counterstained with DAPI (blue). Bar represent A-B 10 µm, C 5 
µm. 
 
3.3.7. Effect of MyD88 deficiency on DC maturation 
To determine the role of the MyD88 signaling pathway in E. faecalis-induced maturation of 
DCs it was investigated whether MyD88 is essential for E. faecalis-induced IL-12 production 
and release by DCs. Wild-type, TLR2 
-/-
 and MyD88 
-/-
 DCs were infected with E. faecalis for 
2h and further cultured in the presence of 100 µg/ml penicillin/gentamicin. The supernatant of 
DCs stimulated with heat-killed bacteria was used as a positive control. The levels of IL-
12p70 in the supernatants were measured 24h after infection by ELISA. As shown in FIG 
3.18., secretion of IL-12p70 was abolished completely in MyD88 
-/-
 DCs infected with E. 
faecalis, but only reduced moderately in TLR2 
-/-
 derived DCs. These results indicate that E. 
faecalis induction of IL-12p70 is almost completely dependent on MyD88 signaling and 
independent of TLR2 indicating that other PRRs besides TLR2 play a role in this process. 
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FIG 3.18.: DCs from TLR2 or MyD88 
-/-
 mice release lower levels of IL-12 p70 than wild-type 
cells in response to E. faecalis. To identify the involvement of TLR2/MyD88 signaling in the 
maturation process of DCs during infections with E. faecalis, DCs derived from wild-type, TLR2 
and MyD88 knockout mice were infected with an MOI of 10:1 of E. faecalis and the level of 
released IL-12 p70 was determined by ELISA. (A) wild-type cells, (B) TLR2 
-/-
 and (C) MyD88 
-/-
 
DCs. **, P < 0.01; ***, P < 0.001. 
 
 
3.3.8. Uptake and killing of internalized E. faecalis bacteria by DCs are independent of 
MyD88 expression 
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Cell activation by bacteria via TLR signaling regulates phagocytosis at multiple steps, 
including internalization and phagosome maturation [160-162]. Therefore, it was assessed 
whether DCs that lacked MyD88 compared to wild type DCs differ in their ability to 
internalize E. faecalis by counting the level of viable intracellular bacteria 24h post infection 
in bone marrow derived DCs. In contrast to the phenotype of these cells according to the 
induction of maturation marker and activation of inflammatory cytokine release, MyD88 
expression did not affect the ability of DCs to internalize and kill E. faecalis, because the 
uptake of these bacteria by MyD88 
-/-
 DCs (FIG 3.19. A) was comparable to the level of wild-
type DCs.  
 
 
 
FIG 3.19.: DCs from TLR2 or MyD88 knockout mice have the same killing potential than wild-
type cells. DCs from TLR2 or MyD88 knockout mice were infected as described in 2.12.2 and 
intracellular bacteria were counted 24h post infection. (A) No difference in the killing ability was 
observed among the different cell types. Each bar represents the mean ± SD of three independent 
experiments. ***, P <0.001. 
 
 
3.3.9. Secretion of KC and MIP2 by DCs in response to E. faecalis is MyD88-dependent  
Next, it was investigated if MyD88 was involved in the production of other inflammatory 
cytokines, such as KC and MIP2, these cytokines are shown to have an impact on the 
recruitment and infiltration of phagocytes to the site of infection [163]. These cytokines were 
detected by ELISA in the supernatants of uninfected and E. faecalis infected wild-type, TLR2 
-/-
 or MyD88 
-/-
 DCs 24h after in vitro infection. Wild-type DCs and MyD88 
-/-
 DCs were 
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stimulated with heat-killed enterococci as controls. The production of both cytokines - KC 
(FIG 3.20. A and C) and MIP2 (FIG 3.20. D and F) - in response to E. faecalis infection was 
significantly reduced in MyD88 
-/-
 DCs compared to wild-type cells. These data indicate that 
E. faecalis-induced production of proinflammatory cytokines in DCs is strongly TLR2 
mediated and depends on MyD88 signaling. 
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FIG 3.20.: KC and MIP2 release of DCs after infection with E. faecalis. DCs from TLR2 or 
MyD88 knockout mice were infected as described in section 2.12.1 and the amount of KC and 
MIP2 was measured. As shown in (A) DCs from wild-type mice release high levels of KC after 6h 
which is decreasing over time. (B) TLR2 
-/-
 DCs showed a delayed release of KC peaking at 24h 
post-infection. (C) MyD88 
-/-
 DCs are markedly impaired in their ability to release KC. MIP2 
levels from DCs of wild-type mice (D), TLR2 
-/-
  DCs (E) and MyD88 
-/-
 cells (F) showed similar 
release patterns as described before for the chemokine KC. Each bar represents the mean ± SD of 
three independent experiments. *, P <0.05; **, P < 0.01; ***, P < 0.001. 
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In conclusion, these results indicate that immune recognition of E. faecalis by DCs is highly 
diverse and requires a coordinated interplay between MyD88-independent events involving 
phagocytosis as well as MyD88-dependent signaling pathways involved in the induction of 
DC maturation and cytokine production. The data further indicate an important role of DCs in 
the host defense towards this microorganism.  
 
3.4. Interaction of E. faecalis with endothelial cells  
The endothelium is a single cell thick barrier within the blood vessels, which separates blood 
from deeper tissue. ECs express surface markers like intercellular adhesion molecule 1 
(ICAM-1 or CD54), vascular cell adhesion protein 1 (VCAM-1 or CD106) and mucosal 
addressin cell adhesion molecule 1 (MAdCAM-1) which are necessary for the migration 
process of leukocytes through the endothelium [128]. Endothelial cells are also important 
immune modulators with various regulatory properties on other branches of the immune 
system [129]. Furthermore, they provide anti-pathogenic functions through the release of 
antimicrobial peptides [145]. 
E. faecalis is able to induce endocarditis by establishing a biofilm on the heart bulb or in 
middle heart blood vessels. Because the endothelial barrier is the first line of the host innate 
immune response encountering enterococci when they enter the blood stream, the interaction 
with these cells is of central interest. To better understand the colonization of the endothelium 
in disease, it is necessary to unravel the molecular and cellular processes taking place during 
the interaction of enterococci with endothelial cells.  
  
3.4.1. E. faecalis is able to adhere to but does not internalize into endothelial cells  
Many pathogens use intracellular compartments to protect themselves from cells of the host 
immune defense like PMNs or macrophages. A few studies indicated an intracellular stage for 
E. faecalis [164]. The internalization into eukaryotic cells is a process that can be initiated by 
pathogens through active invasion or by phagocytosis of host cells [165]. 
To address this question, HUVECs were infected as described in section 2.12.2. After 2h the 
cells were washed twice with 1x PBS to remove extracellular bacteria and were cultivated 
further for up to 22h in the present of 100 µg/ml penicillin/streptomycin and 100 µg/ml 
gentamicin. Samples of infected HUVECs were taken after four, seven and 24h post-
infection. HUVECs were washed twice with 1x PBS to remove extracellular antibiotics. Then 
the cells were lysed with 0.1% Triton X-100 and intracellular bacteria were plated on BEA 
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agar plates. The numbers of viable, intracellular E. faecalis within HUVECs were counted. 
Interestingly, almost no intracellular bacteria could be detected. Only one cell out of 200 
showed an intracellular presence of bacteria 4h post infection. Low levels of intracellular 
bacteria were detectable up to 24h post-infection. 
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FIG. 3.21.: E. faecalis shows very low frequency of intracellular bacterial presence within 
HUVECs. Endothelial cells were infected with an MOI of 10:1 bacteria per cell as described in 
section 2.16.2. The numbers of intracellular bacteria were counted after 4h, 7h and 24h post 
infection (p.i.) by plating live bacteria on BEA-plates in serial dilutions. The line represents the 
mean ± SD of three independent experiments. 
 
 
To strengthen these findings double immunofluorescence microscopy was applied. HUVECs 
were infected with live bacteria at an MOI of 10:1 bacteria per cell as described in 2.12.2 and 
stained as described in 2.13.2. The intracellular bacteria appear in red, extracellular bacteria 
appear in yellow. A representative picture is depicted in FIG. 3.22. (A and B). Almost no 
intracellular bacteria were found within the endothelial cells. These data support the counting 
of viable intracellular bacteria obtained by plating serial dilutions of lysed endothelial cells.   
 
 
 68 
 
 
 
FIG. 3.22.: Representative double immunofluorescence image of HUVECs infected with E. 
faecalis. Endothelial cells were infected with an MOI of 10:1 bacteria per cell as described in 
section 2.16.2., stained as described in section 2.13.2. (A) Non-infected control. (B) E. faecalis 
infected HUVECs 24h post-infection showing no presence of intracellular bacterial within 
endothelial cells. One representative image out of ten experiments is shown. Bar in A and B 
represents 50 µm. 
 
 
3.4.2. Cytokines involved in the chemotaxis of neutrophil recruitment are manipulated 
by E. faecalis  
As a main source for cytokine and chemokine release endothelial cells play a crucial role in 
the recruitment of innate immune cells [130-133]. One of these cytokines is the 
proinflammatory cytokine IL-8 which is the most predominant attractant for the recruitment 
of polymorphonuclear neutrophils (PMNs) to the site of infection [163]. To obtain the 
cytokine profile in the course of E. faecalis infections, HUVECs were co-cultivated with E. 
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faecalis as described in section 2.12.2 with an MOI of 10:1. 2h after infection a mixture of 
100 µg/ml penicillin/streptomycin/gentamicin was added into the cell culture to kill 
extracellular bacteria. The cells were incubated further for 22h. After 24h of total infection 
time, the supernatant was collected and an ELISA to detect the released levels of IL-8 was 
performed as described in section 2.14.2. 
The amount of IL-8 determined in the cell culture supernatant of E. faecalis infected cells 
reached the level of uninfected control cells, whereas heat-killed E. faecalis induced a 
significant increase in the release of IL-8 by endothelial cells (FIG. 3.23.).   
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FIG. 3.23.: IL-8 released by HUVECs after infection with E. faecalis. During infection with live 
bacteria (described in section 2.12.2) no release of the proinflammatory cytokine IL-8 by HUVECs 
could be detected, whereas heat inactivated enterococci are able to mount a significant IL-8 release 
by HUVECs E. faecalis. Each bar represents the mean ± SD of four independent experiments. ***, 
P < 0.001. 
 
 
The diminished response of endothelial cells during infection with live E. faecalis bacteria 
compared to the response elicited by heat-killed microorganisms indicated that actively 
produced and released factors of E. faecalis are responsible for the down-regulation of IL-8 
secretion by endothelial cells after they have encountered the bacteria. 
   
3.4.3. No cytotoxicity on endothelial cells by E. faecalis infection 
To investigate the role of E. faecalis-induced cytotoxicity on endothelial cells that could 
interfere with the observed diminished IL-8 response, the release of lactate dehydrogenase 
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(LDH), an enzyme associated with necrotic cell death, was determined. LDH serves as 
indicator of necrotic cell death caused by an external influence or trigger [166, 167].  
Briefly, HUVECs were infected as described in section 2.12.2. with E. faecalis. No LDH 
release was detectable in cells infected with enterococci suggesting absolutely no cytotoxic 
effect on endothelial cells. 
 
3.4.4. E. faecalis manipulates the expression of the endothelial surface receptor involved 
in leucocyte extravasation ICAM-1 during infection 
HUVECs cells recruit PMNs via release of IL-8. The expression of endothelial surface-
associated receptors like ICAM-1 (CD54), E-selectin (CD62-E) and VCAM-1 (CD106) 
promotes rolling of PMNs and the extravasation of PMNs into infected tissue. The expression 
and the availability of these receptors are critical for clearance of bacterial infections.  
To investigate the influence of E. faecalis infection on the expression of these surface 
markers, HUVECs were infected with E. faecalis at an MOI of 10:1 as described in 2.12.2. 
Because IL-1β is one of the most prominent inducers for ICAM-1 expression [168], 
endothelial cells were stimulated with recombinant IL-1β at 1 ng/ml as a positive control 
(FIG. 3.24.).  
 
 
FIG. 3.24.: Flow cytometry analysis of ICAM-1 (CD54) surface expression after infection with E. 
faecalis. 5x10
4
 HUVECs were infected with an MOI of 10:1 with E. faecalis and analyzed by flow 
cytometry. (A) The presence of the surface receptor CD54 was analyzed and quantified by the 
mean fluorescence intensity. The expression during infection with enterococci (orange) was 
compared to a non-infected control (red) and HUVECs treated with recombinant IL-1β as positive 
control (light blue). Unstained control cells are represented in green. One representative result out 
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of three is shown.  (B) MFI of CD54 surface expression was calculated on E. faecalis infected 
cells. Each bar represents the mean ± SD of three independent experiments. ***, P < 0.001. 
 
 
This finding together with the moderate induction of the chemotactic cytokine IL-8 underlines 
the possibility that E. faecalis has evolved strategies to interfere with the inflammatory 
response of the endothelium (FIG. 3.24.) on the level of cytokine release and chemoattraction 
of phagocytes. 
 
3.4.5. E. faecalis is also affecting the expression of E-Selectin and VCAM-1 on the 
surface of endothelial cells 
Leukocyte extravasation is not only based on the expression of surface receptor ICAM-1, but 
also on the expression of E-selectin and VCAM-1. To better understand how E. faecalis 
manipulates the extravasation process of leukocytes, the surface expression of E-selectin and 
VCAM-1 in response to E. faecalis was also analyzed (FIG. 3.25.). As already demonstrated 
for ICAM-1 (FIG 3.25. A), E. faecalis induces only a moderate expression of the 
extravasation receptors E-selectin (B) and VCAM-1 (C) compared to IL-1β-induced 
expression of these receptors. These findings indicate that E. faecalis is able to hinder the 
surface expression of extravasation receptors on endothelial cells and therefore, the 
recruitment of inflammatory cells (e.g.  PMNs) to the site of infection.  
 
 
 
FIG. 3.25.: Surface expression of ICAM-1; E-selectin and VCAM-1 on endothelial cells during 
infection with E. faecalis. 5x10
4
 HUVECs were infected with an MOI 10:1 of E. faecalis and 
analyzed by flow cytometry. All extravasation receptors, ICAM-1 (A), E-selectin (B) and VCAM-
1 (C) show only moderate surface presence after stimulation with E. faecalis compared to IL-1β 
stimulated cells which served as positive control. Infected cells (orange) were compared to a non-
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infected control (red) and an IL-1β treated positive controls (light blue); an unstained control is 
shown in green. One representative result out of three is shown.  
 
3.4.6. Expression of leukocyte extravasation receptors on endothelial cells after infection 
with E. faecalis is independent on host genetics and donor specificity 
To investigate the influence of host genetics and cell variability on E. faecalis induced 
extravasation receptor expression, HUVECs of different origins representing the diversity of 
human donors were used in co-cultivation studies.  
M
e
a
n
 f
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
[a
b
s
o
lu
te
]
 C
TR
24
h 
IN
F  
IL
-1
0
2000
4000
6000
8000
20000
40000
60000
n. s.
***
M
e
a
n
 f
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
[a
b
s
o
lu
te
]
 C
TR
24
h 
IN
F  
IL
-1
0
5000
10000
15000
20000
25000
n. s.
***
M
e
a
n
 f
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
[a
b
s
o
lu
te
]
 C
TR
24
h 
IN
F 
IL
-1
0
2000
4000
6000
8000
50000
100000
150000
200000
n. s.
***
M
e
a
n
 f
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
[a
b
s
o
lu
te
]
 C
TR
24
h 
IN
F  
IL
-1
0
2500
5000
50000
75000
100000
n. s.
***
M
e
a
n
 f
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
[a
b
s
o
lu
te
]
 C
TR
24
h 
IN
F 
IL
-1
0
5000
10000
100000
150000
200000
n. s.
***
M
e
a
n
 f
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
[a
b
s
o
lu
te
]
 C
TR
24
h 
IN
F 
IL
-1
0
5000
10000
100000
150000
200000
n. s.
***
A B
DC
E F
PROMOCELL SCIENCELL
ICAM-1
E-selectin
VCAM-1
24h p. i. 24h p. i.
 
FIG. 3.26.: Surface expression of ICAM-1, E-selectin and VCAM-1 on HUVECs of different 
origins, representing a unique donor spectrum after co-cultivation with E. faecalis. HUVECs were 
 73 
 
infected as described in section 2.12.2 for 24h with an MOI of 10:1 with bacteria and the cells 
were analyzed by flow cytometry as described in section 2.14.3. Right panel (A; C; E) shows the 
response of HUVECs from PROMOCELL; left panel (B; D; F) the response of HUVECs from 
SCIENCELL. Each bar represents the mean ± SD of three independent experiments.  
Briefly, HUVECs (PROMOCELL, SCIENCELL) were co-infected with E. faecalis at an 
MOI of 10:1 as described in section 2.12.2. After 24h the cells were stained for ICAM-1, E-
selectin and VCAM-1 and analyzed by flow cytometry. The mean fluorescent intensity (MFI), 
obtained by flow cytometry analysis is depicted in FIG 3.26.  
No difference was observed in the surface presence of ICAM-1, E-selectin and VCAM-1 on 
endothelial cells from two origins. These findings support an enterococcal component based 
and host independent characteristic of the observed weakening effect of endothelial 
extravasation marker expression during infection with E. faecalis.  
 
3.4.7. Comparison of activation pattern between E. faecalis, S. aureus and E. coli 
stimulated HUVECs  
To further confirm the ability of enterococci to manipulate the expression of endothelial 
surface receptors involved in the extravasation process of leukocytes, in comparison to 
bacteria known to induce the expression of these receptor [169-171] the response of HUVECs 
to infection with S. aureus and E. coli was investigated for the expression of ICAM-1, E-
selectin and VCAM-1 compared to E. faecalis.   
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FIG 3.27.: Surface expression of ICAM-1, E-selectin and VCAM-1 on HUVECs stimulated 
with E. faecalis, S. aureus or E. coli. The difference in the expression of these surface receptors 
was detected by flow cytometric analysis ICAM-1 as well as VCAM-1 are significant higher 
expressed in cells infected with S. aureus or E. coli compared to non-infected control cells.  
HUVECs infected with E. faecalis do not show upregulation of these surface receptors compared 
to the uninfected control cells. Interestingly the expression of the E-selectin was not significantly 
different under all infection conditions compared to non-infected cells. Each bar represents the 
mean ± SD of three independent experiments.  ****, P < 0.0001.  
 
 
These data underline that in comparison to other bacterial pathogens like S. aureus or 
opportunistic organisms like E. coli., E. faecalis manipulates the expression of surface 
receptors responsible for leukocyte extravasation for its own benefit. This indicates an 
immune evasion strategy in which the docking and therefore the infiltration of neutrophils 
through the endothelial barrier is blocked. 
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Nevertheless, further experiments will have to be performed to unravel the underlining 
molecular processes involved in this silencing effect that E. faecalis is able to induce on the 
endothelial  barrier. 
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4. Discussion 
Enterococcus faecalis is the main cause of enterococcal bacteremia and nosocomial 
bloodstream infections in the hospital environment [11]. Up to 90% of enterococcal infections 
in humans are caused by the opportunistic pathogen E. faecalis [172]. Enterococcus diseases 
are meanwhile among the most common reasons for nosocomial infections in the US and 
Europe. About 12% of all nosocomial infections in the US and 26.5% of urinary tract 
infections in Germany for example are caused by this pathogen [16, 17]. The increasing 
problems of life-threatening infections induced by this organism demonstrate the need for 
intensive investigation on host pathogen interactions during enterococcal infections. 
Most virulence studies and infections of enterococci have been performed using E. faecalis 
strains. This enterococcus species is not only responsible for most of the enterococcal 
infections, its virulence abilities are also less difficult to manipulate compared to other 
enterococcal species like E. faecium. Nevertheless, the secreted factors, as well as the surface 
localized virulence properties, which have been found to be involved in the severity of 
infection caused by this bacterial family is very similar between both bacterial species. Since 
the beginning of the antibiotic era these bacteria are a challenge for the medical field because 
of their multiple variants of antibiotic resistances [24, 25]. The need for adaptive 
combinations of antibiotics to successfully treat severe enterococcal infections, like infective 
endocarditis is therefore increasing [10].  
For blood stream infection and sepsis E. faecalis has become a serious issue in North America 
and in Europe [19, 21]. Furthermore there are also case-reports of infection of the respiratory 
tract, osteomyelitis, cellulitis and infection of the central nervous system and even meningitis 
[22, 23], reported to be causally determined to enterococci underlining the broad spectrum of 
diseases that can be provoked by this opportunistic microorganism.  
 
The increased incidences of enterococcal infections in Germany [173] have not been linked to 
a remarkable variability in virulence or severity so far [174]. Nevertheless, the reasons for the 
change in the epidemiology and clinical manifestations of enterococcal infections are still 
unknown. An area of intensive investigation remains whether this dramatic rise in the 
incidence of severe infections caused by enterococci resulted from changes in virulence 
characteristics or if this phenomenon is associated with increased susceptibility of the host 
presumably because there is a lack in mounting a protective immune response towards these 
bacteria. All possibilities do not seem to be exclusive, and there is little doubt that the disease 
outcome is also strongly determined by the host-pathogen interplay. 
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Therefore, one of the initial steps in this project was to screen a collection of well-
characterized clinical isolates for the presence/absence of virulence factors known to be 
involved in the pathogenesis of enterococcus diseases and to search for correlations between 
disease manifestations on one side and the genetic basis of the bacteria on the other side.  
The main virulence factors of E. faecalis are genes located on a 153 kb pathogenicity island 
(PAI) of these bacteria [32, 33]. The majority of these genes are responsible to enhance the 
colonization potential of enterococci but also cytotoxins or stress response proteins are 
encoded in the PAI region.  
In this study the genes for adhesion of collagen binding by E. faecalis (ace), aggregation 
substance (as), cytolysin A (cylA), which is part of the cytolysin activation process, 
enterolysin A (elyA), enterococcal surface protein (esp), endocarditis and biofilm-associated 
pilus (ebpABC), endocarditis antigen (efaA), gelatinase E (gelE) and hyaluronidase (hyl) were 
analyzed with respect to the disease manifestation of the corresponding strain.  
Additionally, the ability of clinical isolates to completely lyse erythrocytes (β-hemolysis) was 
tested, but could not be connected to the expression of the two known cytolysins CylA or 
ElyA. The discrepancy of the presence of the coding gene and the protein might be due to the 
complexity of the machinery responsible for the release of cytolysins. Cytolysin consists of 
two subunits called CylL” and CylS”. These two subunits were modified by an extracellular 
protease called CylA. Without this modification, the two subunits are not able to establish a 
pore within the membrane of host cells [37, 175]. In this study not all of the related genes 
involved in the production and modification of a full functional protein cluster were 
investigated which could be the reason for the gap between the presence of the gene cylA and 
the lack of β-hemolysis activity. A summary of the results is depicted in the appendix (table 
10).  
In this study no correlation could be found between the genotype and disease manifestation. 
The imbalance between enterococcal virulence attributes and specific host immune defense 
properties is highly likely the reason for the ability of E. faecalis to colonize, invade and 
damage host tissue. However, the molecular and evolutionary mechanism leading to this 
imbalance is still not clear. Defining virulence mechanisms employed by E. faecalis and 
characteristics of the host that contribute to pathogenesis will facilitate the development of 
both pharmacological and immunological therapies. 
Despite the fact that E. faecalis is an emerging nosocomial pathogen causing increasing 
problems not only in ICUs or in immunocompromised patients, but also for patients 
undergoing surgery, the knowledge of how this pathogen is interacting with the host immune 
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system and which processes are involved in the onset, progression and pathogenesis of 
diseases caused by E. faecalis is still extremely limited. Only a few studies have attempted to 
investigate this area systematically. This knowledge, however, could lead to new strategies of 
how to improve the natural host resistance to this emerging pathogen. Investigations to 
unravel the interaction of enterococci with host immune cells have been strongly focused on 
the role of professional phagocytic cells so far. In this regard, several reports have highlighted 
a crucial role of PMNs in the early control of E. faecalis [55]. It has been shown that 
opsonization of E. faecalis and killing by PMNs play a central role in the host immune 
response to enterococci [55]. Also the translocation of E. faecalis in mice, leading to sepsis 
was shown to be dependent on functional PMNs [56]. The findings in this work also argue for 
a potential intracellular survival of enterococci within phagocytic cells. 
A factor responsible for the intracellular survival in macrophages seems to be PerA [57].  
According to Zou and Shankar PerA inhibits the activation of the lysosomes and the fusion of 
lysosomes and endosomes, enabling the bacteria to survive within macrophages for a long 
time period intracellularly [58].  
Therefore, one aim of this study was to gain deeper mechanistic insight into the interaction of 
E. faecalis with cells of the host immune system, especially focusing on innate immune cells 
that have not been investigated in great detail. In addition to phagocytes, various other 
immune cell types are of pivotal importance in the coordination of an effective immune 
response. Sentinel cells composing the first line of immune defense against invading 
pathogens are mast cells, dendritic cells or in particular cells building up the endothelial 
barrier. The interaction and meaning of these cells during infections caused by enterococci is 
not a strong focus of research up to now or the results are conflicting and contradictory. 
 
So far, sentinel cell types underestimated in the context of infectious disease per se are MCs 
[84, 93, 176], which have been linked and intensively investigated for their role during 
allergic reactions. Nonetheless, the interest on the antimicrobial properties of these cells is 
increasing. MCs are inflammatory cells, which are typically located immediately beneath the 
epithelial surfaces exposed to the outer environment such as the skin and the mucosa, but also 
the respiratory system, genitourinary and gastrointestinal tract [94]. Because many of these 
sites are also common entry ports for pathogens, MCs represent one of the first inflammatory 
immune cells encountered by an invading microorganism and initiating the host immune 
response against these microbes [177]. Recent evidences have suggested that MCs have a 
beneficial contribution to both innate and adaptive immunity during infection [178], because 
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MCs are able to release pre-stored and newly synthesized inflammatory mediators as well as 
antimicrobial acting substances into their surrounding upon contact with pathogens [93, 94]. 
In this study, an in-depth characterization of the interactions of E. faecalis with MCs was 
performed. 
The results demonstrated that E. faecalis is not only able to adhere to MCs, but also to 
stimulate an inflammatory cytokine response by the release of IL-6 or TNF-α. IL-6 release by 
MCs was recently shown to be important to regulate the selective influx of other immune cells 
like dendritic cells (DCs) into inflamed lymph nodes, thus enhancing opportunities for 
effective T-cell-DC interaction. These interactions induce an effective adaptive immune 
response to bacterial pathogens [85]. In particular, the release of TNF-α by local MCs are an 
important protective response elicited by MCs to enterococcal infection, because TNF-α serve 
as a central chemoattractant for phagocytes, like PMNs and macrophages, important for 
elimination of this pathogen [56, 179]. Nevertheless, also an intracellular persistence of E. 
faecalis in macrophages has been reported [57, 164, 180] illustrating that E. faecalis has also 
evolved strategies to manipulate host immune defense mechanism. 
Interestingly, no evidence could be found in this study that E. faecalis is able to actively 
invade or even persist in great numbers within MCs. This is in contrast to other Gram-positive 
pathogens like Staphylococcus aureus [90] or Gram-negative bacteria like Escherichia coli 
[181]. These bacteria gain access into mast cells without the loss of bacterial viability by a 
route distinct from the classical endosome-lysosome pathway and are even able to persist for 
long time periods within MCs. If MCs were infected with opsonized heat-killed Salmonella 
typhimurium or other opsonized enterobacteria, an efficient phagocytosis of these organisms 
was observed underlining the phagocytic properties of these cells [95, 96]. 
MCs have been shown to be able to kill bacteria by two different mechanisms [89, 90, 97, 
182]: (1) phagocytosis (mainly Gram-negative bacteria) and/or (2) extracellular by 
degranulation and the release of antimicrobial peptides such as LL-37, which affects several 
bacteria, like S. aureus [90] or by the formation of so called mast cells extracellular traps 
(MCETs) which has been shown to be important in the efficient killing of S. pyogenes [97]. 
This study could also prove that MCs were activated after encounter of E. faecalis and exerted 
a direct antimicrobial activity against this pathogen via several extracellular mechanisms. 
One of those mechanisms involves the formation of extracellular traps. Immunofluorescence 
microscopical studies revealed that E. faecalis is able to induce a certain level of MCETs 
formation and could also show that at least some of the entrapped bacteria were killed within 
the MCET structure [158]. The level of MCET formations was not as pronounced as it has 
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been reported for other pathogens like S. pyogenes [97]. Treatment with nucleases also did not 
completely abolish the antimicrobial function of MCETs. This leads to the conclusion that 
entrapment by MCETs, which are produced by infected MCs, seems to be not the only 
mechanism by which these cells are able to interfere with the bacterial growth of enterococci.  
Another extracellular mechanism employed by MCs in response to E. faecalis is 
degranulation. Recent studies have shown that degranulation leads to an effective killing of 
various Gram-positive as well as Gram-negative bacteria [183]. The blocking degranulation 
of MCs by cromolyn could restore bacterial growth, which was observed in the presence of 
MCs indicating an important role in the antimicrobial response of MCs during infections with 
E. faecalis. MC degranulation may be accompanied by the release of antimicrobial peptides 
such as cathepsin G or cathelicidins [88, 184], which are known to inhibit bacterial growth of 
various Gram-positive bacteria such as S. pyogenes or S. aureus [88, 185, 186]. An important 
antimicrobial peptide released by MCs is the cathelicidin LL-37 [88, 98].  
The results presented in this thesis show that E. faecalis is very sensitive towards the anti-
microbial effect of cathelicidin LL-37, indicating a potential major role of this anti-microbial 
peptide in the antimicrobial activity of MCs against E. faecalis. Electron microscopy 
examination revealed that E. faecalis exposed to either MCs or to LL-37 developed vesicle-
like structures on the bacterial surface. Such vesicles have been described mainly for Gram-
negative microorganism like E. coli [183], Salmonella enterica [187] or Pseudomonas 
aeruginosa [188] and some Gram-positive microorganisms like S. aureus [189]. The function 
of these vesicles is not yet clear but they may be related to bacterial responses towards 
environmental stress, which in this study might be produced by the anti-microbial compounds 
of MCs acting on the bacterial cell wall. 
LL-37-treated E. faecalis showed morphological changes of the membrane. These vesicle-like 
formations are similar to structures found on S. pyogenes when they were treated with LL-37 
[99]. The treatment of E. faecalis leads to a significant lower bacterial growth compared to an 
untreated control [158]. When E. faecalis is co-cultivated with MCs, similar vesicle-like 
structures can be observed [158]. This finding would be the first report of vesicle-like 
structures induced on the surface of enterococci by LL-37 [158] and might highlight the mode 
of action by which this antimicrobial peptide interferes with the growth of enterococci.  
Taken together degranulation as well as the release of antimicrobials are another important 
extracellular control mechanism of MCs to limit bacterial growth of this pathogen. The 
bacterial factors involved in the induction of MCs degranulation after exposure to E. faecalis, 
however, remain to be determined in future studies. Common bacterial factors form Gram-
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positive bacteria inducing degranulation of MCs are mostly exotoxins like the δ-toxin of S. 
aureus or the hemolytic pigment/lipid toxin form group B streptococci [190, 191]. Next to 
these bacterial factors there are several other inducers of degranulation of MCs including 
chemicals, drugs and environment factors [159, 192-194].  
 
There are multiple direct and indirect pathways by which MCs can be selectively activated by 
pathogens including TLRs, co-receptors and complement receptors. TLRs are of central 
importance. Signaling via these receptors guides the immune system to produce an effective 
immune response to invading pathogens. It still is not well understood by which mechanisms 
TLRs are able to distinguish between a pathogen and a harmless commensal organism [195].  
The recognition of bacterial pathogens by host cells is to a great extent mediated by the 
TLR/MyD88 pathway [196-198] while the classical activation of MCs is induced by 
interaction of dimerized IgE with the FcεRI receptor [199]. However, the interaction of TLRs 
with PAMPs also initiates the activation and degranulation of MCs [200]. 
The specificity of TLR recognition has been identified for several important PAMPs, 
including recognition of peptidoglycan (PGN), bacterial lipoproteins and zymosan by TLR2, 
double-stranded RNA by TLR3, LPS and heat-shock proteins (HSPs) by TLR4, flagellin by 
TLR5 and CpG motifs of bacterial DNA by TLR9 [201]. TLRs are expressed on many cell 
types including MCs. A critical role for TLRs in recognition of microorganisms or microbial 
products resulting in a complete and effective host defense has been established. E. faecalis 
expresses a variety of PAMPs that are recognized by TLRs [202, 203]. The precise TLR 
signaling and downstream events during the initial phase of infection with E. faecalis remains 
largely unknown, therefore, in this study one important focus was to shed light into which 
receptors are involved in E. faecalis interaction with MCs. MCs are more and more 
recognized to play an important role in the immune defense against bacterial pathogens, 
besides their traditional role in allergy immunity to parasites [204, 205]. The contributions of 
TLR-mediated mechanisms and subsequent effector functions of MCs during enterococcal 
infection are largely unknown. Beside the unclear state of TLR-mediated mechanisms 
involved in the response to enterococci, there is also only little knowledge about the 
composition of TLRs expressed by MCs. Twelve different TLRs are present in the genome of 
mice and ten in the human genome [69]. Using ex vivo MCs or MCs differentiated from bone 
marrow as well as cell lines, the composition of TLRs on MCs was described as a 
combination of TLR1-4 and TLR6-9 that are all present on BMMCs, while TLR5 and 10 was 
not detectable on these cells in several different studies [200, 206-211]. The involvement of 
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some TLRs in the immune response to enterococci have been demonstrated in recent studies, 
involving the recognition of enterococcal nucleic acids by the endosomal TLR7 and 9 in 
macrophages [212]. In the frame of this work immune responses mediate by TLR2, one of the 
most important TLR in terms of Gram-positive bacteria was investigated. This interaction is 
of particular interest, because it has been recently shown that TLR2 signaling in MCs is 
crucial for the effective control of other pathogens like Francisella tularensis [196].  
Even though no difference in the association of E. faecalis to wild type or TLR2 
-/-
 MCs could 
be detected, wild type MCs release significantly higher amounts of IL-6 compared to TLR2 
-/-
 
cells 6 h post-infection. Interestingly, no difference was found in the release of TNF-α, which 
is pre-stored in secretory granules and released upon different triggers. This finding is 
particularly unexpected, because TLR2 
-/-
 cells display a significantly reduced degranulation 
response as measured by the release of β-hexosaminidase by knock-out cells compared to 
wild type MCs. Thus, suggesting a clear role of TLR2 signaling in the degranulation process. 
These findings can be explained by the fact that the release of distinct secretory granules 
subsets is highly regulated by different SNARE isoforms [213], directing the fusion of 
different cellular compartments in response to cellular signaling processes. Further studies 
have to demonstrate whether the impact of TLR2 really alters effects on the extracellular 
killing abilities of MCs in the course of E. faecalis infections in vivo.  
Interestingly, it could be also demonstrated in the frame of this study that the formation of 
vesicle-like structures on the surface of E. faecalis is diminished if these cells are co-
cultivated with MCs deficient for TLR2 or MyD88. This observation also highlights the role 
of TLR/MyD88 signaling for degranulation in general and LL-37 release in particular of MCs 
[158].  
The formation of MCETs on the other hand was shown to be a TLR/MyD88 independent 
mechanism as demonstrated by the fact that MCETs formation of MCs in response to E. 
faecalis did not differ between TLR2 or even MyD88 knock out cells to cells of wild type 
[158].  
In summary, this study provides the first experimental evidence that MCs exert antimicrobial 
activities against enterococci by extracellular mechanisms and thereby supporting a protective 
effect of MCs against this emerging pathogen. Furthermore, some details could be provided 
regarding the importance of TLR/MyD88 signaling in the immune response of MCs to E. 
faecalis and in particular in the degranulation of MCs triggered by E. faecalis. 
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Host defense against infection always requires an integrated response of both, the innate and 
the adaptive branches of the immune system. The innate immune defense system consists of 
many different cellular and humoral components that act in a coordinated fashion to prevent 
the manifestation of infection diseases. DCs are of central importance for initiating immune 
responses against invading pathogens. Next to MCs, dendritic cells (DCs) are also found on 
sites within the host that are exposed to the environment which makes them perfect sentinels 
for the recognition of pathogenic bacteria [105]. Therefore, another objective of this thesis 
was to elucidate the interaction of DCs with E. faecalis.  
First, in vivo observations in this study using a GFP-expressing E. faecalis strain in a 
peritoneal infection model clearly demonstrated a close association of E. faecalis with DCs in 
vivo and second, a significant infiltration of these immune cells into the peritoneal cavity at 
early time points of infection.  
There is only very limited knowledge available about the interaction of E. faecalis with DCs. 
It has been reported recently that E. faecalis cell surface-associated lipoproteins and the 
enterococcal polysaccharide antigen, which have been shown to be relevant for E. faecalis 
virulence in invertebrate infection models [214], also exhibit colitogenic tendencies in a 
susceptible mouse model, by activating DCs via TLR2 [214]. The loss of the E. faecalis 
lipoprotein signal results in reduced levels of secreted IL-12p40 by DCs. However, these DCs 
have been shown to be still able to reactivate colitogenic T-cells. Interestingly, E. faecalis 
lipoprotein-dependent induction of TNF-α and IL-6 secretion was completely abrogated in 
BMDCs from TLR2 
-/-
 mice [214]. Other studies highlight the properties of probiotic E. 
faecalis strains to modulate the immune response of DCs towards a TH1 response in a TLR 
dependent fashion, enhancing the immune response and shift the cytokine profile to the 
production of inflammatory mediators. The authors argue that probiotic E. faecalis strains 
could be used as a novel adjuvant strategy for oral or systemic vaccination [215].  
All these findings underline the role of DCs as immune modulatory cells upon infection with 
E. faecalis and strengthen the importance to illuminate the cellular processes taking place 
during the encounter of DCs with enterococci. Therefore, a deeper knowledge about their 
implication for beneficial and/or detrimental aspects of immune processes elicited by these 
opportunistic bacteria is necessary.  
The wide distribution of DCs throughout the body enhances their capacity to encounter 
invading microbes. During microbial invasion and tissue destruction, immature resting DCs, 
which have a unique recognition system to monitor danger signals are activated, and undergo 
a defined maturation process [104]. On the one hand activated and matured DCs lose their 
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antigen-capturing ability, but on the other hand they acquire antigen-presenting properties. 
These DCs migrate to the lymph nodes, where they are able to stimulate T cells [216]. Mature 
DCs also express high levels of MHC class II and costimulatory molecules such as CD40, 
CD80, and CD86. Furthermore they produce various cytokines such as IL-12 and TNF-α 
[217, 218] of which IL-12 is of central importance in the coordination of an efficient immune 
response [107].   
In this study it could be also demonstrated that infection of wild-type DCs with E. faecalis 
resulted in a significant upregulation of cell-surface associated DC-activation markers as 
shown by the increased expression of costimulatory molecules such as CD40, CD80 and 
CD86 molecules.  
 
To initiate the cellular responses, E. faecalis has to be recognized by DCs. Recognition of 
microbes by innate immune cells is mediated by PRRs via TLR receptors which main aspects 
have been already discussed in the section above.  
To unravel the contribution of TLRs in the immune recognition and response of DCs to 
infections with E. faecalis, the requirement for the TLR associated adapter molecule MyD88 
in maturation and production of cytokines by DCs after exposure to E. faecalis was 
investigated. MyD88 is the central adaptor molecule for responses several microorganisms or 
their components which are recognized by TLR2, TLR4, TLR5, TLR7, or TLR9. Some TLRs 
such as TLR3 and TLR4 signal via MyD88-independent pathways [219, 220]. The MyD88-
dependent pathway was shown to be generally central for the host defense against microbial 
infections in vivo from a hole variety of different organisms such as S. aureus [221], Listeria 
monocytogenes [222] or Toxoplasmam gondii [223]. The resistance to M. tuberculosis on the 
other hand is affected largely through MyD88-independent pathways [224, 225]; these 
findings however document that the role of MyD88 during infection is very diverse and 
pathogen dependent. Not only devastating but also protective roles have been demonstrated 
for this central adapter molecule. It has been reported that MyD88-deficient mice are 
significantly more protected against the lethal effects of polymicrobial septic peritonitis [226] 
and also show less lethality if they are infected by a high inoculum dose of Group B 
streptococci than wild type mice with an intact MyD88 signaling pathway [227]. 
The beneficial effect of MyD88 displacement and also displacement of the TRIF pathway in 
experimental settings used in these studies seems to be based on the attenuation of a hyper 
inflammatory response and therefore accompanying with a reduced tissue destruction [228]. 
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This might be also a very important issue in the context of enterococcal infections. These 
infections are often developing into a systemic septicemia with severe life-threatening 
conditions that is often initiated by a systemic inflammatory response to the microbe leading 
to impaired perfusion and possible multiple organ failure. 
However, this study was also able to confirm that MyD88 signaling is essential for the 
activation process of DCs and furthermore for the production of IL-12 by DCs in response to 
E. faecalis.  
IL-12 is a heterodimeric proinflammatory cytokine that induces the production of interferon-
gamma and favors the differentiation of TH1 cells and forms a link between innate resistance 
and adaptive immunity [229]. DCs and phagocytes have been shown to produce IL-12 in 
response to pathogens during infection [230]. Although several cell types including DCs and 
macrophages produce IL-12 after exposure to E. faecalis [231, 232], it is not clear which cell 
type is essential to initiate a protective immune response against infection with enterococci. 
 
Although the precise mechanism by which IL-12 contributes to the innate immune defense 
against E. faecalis is not fully understood, studies in murine infection models have shown that 
the production of IFN-γ at the site of infection is in particular induced by IL-12. Moreover, 
the release of this cytokine was critical for mounting an effective innate immune protection 
[233]. Additionally, other studies have also highlighted the importance of IL-12 induced 
production of IFN-γ as essential for mounting an efficient defense response against 
polymicrobial infection via increased antimicrobial activity, nitric oxide production as well as 
increased phagocytic properties of innate immune cells like PMNs [234]. As demonstrated 
here DCs are recruited to the peritoneal cavity of mice infected with E. faecalis within less 
than one hour after infection, thus indicating that these cells are important contributors in the 
host defense towards enterococci most probably by the stimulation of phagocytic and 
microbicidal activities of innate immune cells through the production of IL-12 and 
accompanying local induction of IFN-γ. Murine infection models have also suggested that the 
production of sufficient levels of IL-12p70 early in infection provides a higher level of 
resistance to bacterial infections. This was demonstrated for example for the human pathogens 
S. pyogenes [113, 233, 235].  
In this study it could be clearly demonstrate that the release of IL-12p70 as indicator for a full 
maturation status of DCs in the course of E. faecalis infection was strongly depended on a 
MyD88 based signaling processes, whereas the presence of TLR2 was found to be not 
essential, given by the fact that the production of IL-12p70 was not completely abolished in 
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DCs deficient in TLR2 expression. However, a significant delay in the release of IL-12p70 
could be observed underlying the importance also of TLR2 signaling in initiating an efficient 
release of this important immunomodulatory cytokine. In agreement with the findings in these 
study previous investigations also suggested that the production of IL-12p70 by DCs is 
completely dependent on MyD88 and that loss of this adapter molecule totally abolished the 
production of this cytokine [114, 236]. 
After stimulation with E. faecalis matured DCs are not only releasing classical inflammatory 
cytokines, but also cytokines that are involved in the recruitment of phagocytes. These 
chemotactic active molecules are the CXC motif cytokines KC, responsible for neutrophil 
recruitment to the infection site and MIP2 responsible for the recruitment of macrophages 
[163, 237, 238]. In contrast to the observation made here other Gram-positive bacteria like S. 
aureus have been shown not to induce the release of KC and/or MIP2 in DCs [239], which 
also might argue for an important protective role of DCs in the course of enterococcus 
infections by contributing to high tissue levels of chemotactic mediators like KC or MIP-2. In 
future studies, it needs to be investigated if the ablation of the TLR/MyD88 signaling is 
protective in the course of enterococcal infections in vivo.  
 
Another important feature of DCs is their phagocytic activity, which is decreasing with the 
process of maturation. These properties have been demonstrated already in the early 90s in 
studies using latex beads and zymosan particles which were internalized by DCs [240-242], 
but also apoptotic bodies [243], as well as microbes such as M. tuberculosis Bacille Calmette-
Guérin (BCG) [244, 245], S. aureus [240], Corynebacterium parvis [241], Leishmania spp. 
[246] and Borellia burgdorferi [247]. It also has been shown that this intracellular niche is 
utilized by some pathogenic bacteria, such as S. aureus [109]. In that work it has been 
demonstrated that DCs do not contribute to a direct killing of S. aureus. Using live cell 
imaging the authors demonstrated a rapid increase in the number of intracellular bacteria over 
time as well as the escape of S. aureus into the cytoplasm of DCs followed by intracellular 
replication of the bacteria. For other Gram-positive bacteria like S. pyogenes a clear 
contribution to bacterial killing by DCs could be observed [113].   
Using electron and fluorescence microscopy methods it could be demonstrated that murine 
DCs potently phagocytize E. faecalis. 6h post-infection, no bacteria were detected 
intracellularly arguing for a potent killing capacity of DCs against E. faecalis.  
The lysogenic active compartment of many cells is the phagosome [161]. This compartment 
contains enzymes and an acidic luminal pH of 5.5-6. [248], but also a lot of lysosomal-
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associated membrane proteins (LAMPs) [249]. To gain further insights into the intracellular 
localization of ingested bacteria, a LAMP-1 staining was performed using a GFP-expressing 
E. faecalis strain. Most enterococci within DCs were enclosed within intracellular 
compartments and co-localized with LAMP-1. It has been demonstrated earlier that the 
activation of the TLR signaling pathway by microorganisms is able to elicit phagocytosis at 
various steps of the internalization process and moreover phagosome maturation [160]. 
Interestingly, in contrast to the important impact of the TLR/MyD88 signaling pathway on 
maturation and cytokine release neither phagocytosis nor intracellular killing of E. faecalis by 
DCs was affected by this pathway. BMDCs originated from mice deficient in TLR2 and 
MyD88 showed no difference in the number of internalized bacteria and also no loss of 
intracellular killing ability compared to wild type cells.  
It has to be mentioned that in general the impact of TLR deletion on in vivo phenotypes of 
microbial infections is often not severe. A good example in this aspect is that LPS is a potent 
inducer of TLR4 signaling. However, mice deficient in TLR4 expression do not display a 
higher degree of susceptibility to infection with Gram-negative pathogens [250]. This finding 
was also observed for other bacteria like L. monocytogenes, which is not inducing higher 
susceptibility levels in TLR2 deficient animals [251]. These findings emphasize the 
complexity of immune recognition of invading microorganism by various immune cells. 
However, the data presented in this study underscores a potential protective role of DCs in the 
immune defense against E. faecalis and indicates a coordinated interplay between MyD88-
independent events like phagocytosis and direct bacterial killing of enterococci as well as 
MyD88-dependent processes that involve DC maturation and cytokine release.          
 
Besides resident immune cells representing the first barrier of the host innate immune 
response, like MCs and DCs, the endothelium represents an important first contact point for 
invading microorganism. In particular, biofilm-associated diseases like endocarditis 
established by enterococci as well as blood borne infections, like bacteremia leading to sepsis 
and multiple organ failure, involves the response of endothelial cells.  
Cultured human umbilical vein endothelial cells (HUVEC) have been intensively used to 
study the interaction of Gram-positive and Gram-negative bacteria with the endothelial 
barrier. Nevertheless, there are only a few studies conducted aiming to establish the 
relationship of E. faecalis with endothelial cells. The emergence of high level aminoglycoside 
resistance (HLAR) and vancomycin-resistance gene cluster carrying (VRE) E. faecalis strains 
has limited the success of antibiotic treatment in case of infections caused by this organism 
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and highlighted the importance to study the interaction of these bacteria with their target 
tissues [6, 14]. 
Therefore, the aim of the last part of this thesis was to gain deeper insights of how E. faecalis 
is interacting with this important biological barrier, because one of the most concerning 
disease manifestations caused by enterococcal species is endocarditis. This disease involves 
the interaction of enterococci with endothelial cells of the middle heart blood vessel system or 
on heart valves leading to biofilm formation and subsequently eventually to endocarditis [10]. 
HUVEC are used as an in vitro model to study initial bacteria-endothelial interactions. The 
mechanisms by which enterococci cause endocarditis are still poorly understood and research 
in this field is mainly focusing on the bacterial factors involved in the formation of biofilms. It 
has been shown that E. faecalis is able to adhere to eukaryotic cells by the properties of its 
surface molecules that interact with host cell receptors [180, 252-254]. 
Many pathogens hide inside cells to protect themselves from recognition by cells of the host 
immune defense like neutrophils or macrophages. A few studies indicated also an intracellular 
stage for E. faecalis in macrophages [164] and epithelial cells [255]. E. faecalis were found 
within the intracellular milieu regardless of the fact that E. faecalis is considered to be an 
extracellular pathogen. It also was observed that these bacteria adhere to and invade HUVEC 
cells and hide inside large-scale vacuoles [256]. The ability of E. faecalis strains and clinical 
isolates to enter cultured HUVEC was investigated by these authors and they have shown that 
under the conditions they used E. faecalis was able to enter and survive within HUVECs. The 
ability to adhere and invade endothelial cells was shown and documented also for other 
Gram-positive bacteria like S. aureus and viridian group streptococci [257-260]. On the other 
side other Gram-positive bacteria have been shown not to invade the endothelial barrier, like 
B. subtilis or some S. gallolyticus strains [256, 261]. However, the MOI used in the study of 
Millan and colleagues was relatively high reaching the lowest level at an MOI of 100:1. 
Furthermore, the bacteria were sonicated to avoid bacterial clumping and chain formation. In 
this work only adherence, but no internalization of E. faecalis into endothelial cells was 
observed. This discrepancy might result from cellular variability of endothelial cells used and 
is more important from different experimental settings using more physiological conditions 
for infection at an MOI of 10:1 and without destroying the natural occurrence of bacterial 
chains. Most studies demonstrating E. faecalis inside cells have used cell types with high 
phagocytic properties like macrophages [262] or neutrophils [56]. Therefore, it can be argued 
that appearance of E. faecalis within host cells depends on active phagocytosis and seems to 
be not a result of active invading processes induced by the bacteria [164].  
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A typical response of many host cells to bacterial infection is the release of proinflammatory 
cytokines and mediators. One prominent inflammatory cytokine is IL-8, which is released 
also by endothelium cells [133, 136, 263]. This cytokine is of central importance for 
recruitment of neutrophils to the site of infection as well as for the degranulation of 
neutrophils, which is leading to exocytosis, e.g. histamine release. Endothelial cells are able to 
store IL-8 in their storage vesicles, the so called Weibel-Palade bodies [264]. In target cells, 
IL-8 induces lots of physiological processes being involved in cell migration and 
phagocytosis processes, like increase respiratory burst and Ca
2+
 influx. Different studies also 
have shown the importance of IL-8 and its role in infective endocarditis [265, 266].  
In this study it was described for the first time, that E. faecalis is able to diminish the release 
of IL-8 by endothelial cells. This finding is of interest, because high levels of IL-8 release 
have been reported to be associated with infective endocarditis [267] and have been even 
linked to fatal outcome [265]. Interestingly, this finding is consistent with staphylococcal 
infective endocarditis, in which the level of IL-8 was also reduced [266]. Jijon et al. showed 
in their study that an inhibition of extracellular signal-regulated kinase (ERK) or p38 leads to 
a reduction of IL-8, but not to a reduction of ICAM-1 surface expression [268]. Other study 
showed that wild-type L. monocytogenes are inducing high levels of IL-8, whereas Listeria 
strains deficient in the release of listeriolysin O- or internalin B- as well as other pathogenic 
listeria species like L. innocua, substantially lack the induction of IL-8 production in 
endothelial cells [269]. The bacterial factors being responsible for the reduced release of IL-8 
in the case of E. faecalis-triggered infection of the endothelium remains to be elucidated in 
future studies, potential candidates could be the cytolysins, cytolysin A and enterolysin A 
produced by E. faecalis.  
 
The response of endothelial cells to bacterial infections is often associated with the up-
regulation of receptors involved in process of leukocyte extravasation ICAM-1, E-selectin and 
VCAM-1 [263, 270], which are induced by numerous inflammatory cytokines, in particular 
IL-1β, TNF-α or IL-6 [168, 271, 272] 
Up-regulation of ICAM-1 is induced by cell wall and membrane components of Gram-
positive bacteria like staphylococcal PNGs in various cells, e.g. fibroblasts, which also release 
high levels of inflammatory cytokines like IL-6 and IL-8 [273]. In the work presented here a 
significant reduction in the expression of one of these important surface receptor on 
endothelial cells was observed. ICAM-1 could not only be detected on the level of 
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transcription but even more important not on the level of translation. This effect was not 
limited to the ICAM-1 receptor alone but occurred also for E-Selectin and VCAM-1. The 
functionality of the cells under the experimental conditions used was not affected as could be 
demonstrated by the fact that IL-1β, a strong inducer of the expression of leukocyte 
extravasation receptors [274, 275], showed a normal and strong upregulation of this receptor 
family. 
This finding is of importance, because it suggests together with the diminished levels of IL-8 
induced by this pathogen that E. faecalis is capable to manipulate the response of the 
endothelium for its own benefit, e.g. by impairing the inflammatory immune response elicit 
by endothelial cells. A consequence of this manipulation might be for example that the 
formation of biofilms induced by enterococci and the colonization of heart valve and blood 
vessel tissue is alleviated. This process can evoke also consequences in the manifestation of 
infective endocarditis induced by E. faecalis. The importance of the findings within this study 
is further strengthened by the fact that the cushioned inflammatory response of HUVECs cells 
during infection with E. faecalis is not donor- or cell source-depended, as demonstrated by the 
use of endothelial cells from different origins.    
The molecular mechanisms by which microorganisms or their products are able to manipulate 
the expression of surface receptors involved in leukocyte extravasation are still poorly 
investigated. 
The reduced expression of VCAM-1 in LPS-induced inflammation for example is known to 
be regulated through the novel anti-inflammatory cytokine IL-35, which inhibits the 
expression of this receptor via the AP-1 signaling pathway [276]. Another important factor in 
the regulation of VCAM-1 is the transglutaminase2 (TG-2) that has been documented to be 
necessary for the expression in an NFκB-depended manner. By silencing TG2 using 
inhibitory RNAs (iRNAs), the expression of VCAM-1 was inhibited [277]. It remains to be 
investigated, if these mechanisms are employed by enterococcal strains. 
Up-regulation of E-Selectin is induced in general through NOD1, NOD2 and TLR signaling 
pathways during bacterial infections [278] and is often used as a biomarker for infective 
endocarditis [279]. Under the experimental settings used in this study no significant 
upregulation of E-Selectin could be observed, which might exclude E-Selectin as biomarker 
for infective endocarditis induced by E. faecalis.   
It has been observed that endothelial cells develop a tolerance in terms of E-Selectin 
expression after continuous stimulation with LPS. Therefore, it might be possible that cell 
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wall components of enterococci have the property to induce an anergy in the expression of 
this receptor family, an aspect that would be of interest for further investigations. 
In summary, this wok presents evidence that E. faecalis is able to manipulate the 
inflammatory response of the endothelium by diminishing the release of IL-8 and interfering 
with the surface expression of important receptors involved in leukocyte extravasations in 
particular ICAM-1 and VCAM-1. This offers a new and so far unknown pathogenic property 
of enterococci which might allow the bacteria to circumvent the host immune response and 
enables the bacteria to colonize the endothelium more efficiently. 
 
 92 
 
5. Summary 
 
Enterococcus faecalis has emerged as an important cause of life-threatening bacterial 
infections in the hospital environment especially in ICUs. Enterococcal infections are the third 
most common cause of hospital acquired bacterial infections in the US and in Europe. 
Enterococci have an intrinsic resistance driven by the accumulation of mobile genetic 
elements to many clinically used antimicrobials agents, making them difficult to treat and 
therefore important nosocomial pathogens. 
Surprisingly very little is known about how this opportunistic pathogen interacts with the host 
immune system and modulates its responses. In addition, molecular and cellular processes 
involved in his host-pathogen interaction remain largely unknown e.g. how bacteria enter 
sterile sites of the body to cause disease. Only a few studies have investigated the interaction 
of enterococci with professional phagocytes like macrophages and PMNs. Therefore, one 
major focus of the thesis was to explore how other important and so far neglected sentinel 
cells of the innate immune system, like mast cells (MCs), dendritic cells (DCs) and also the 
endothelial barrier, representing important first counterparts of bacterial pathogens with 
important immunomodulatory functions respond to infections with E. faecalis.  Classically 
MCs are known for their role in allergic reactions and parasite affection, but only a few efforts 
were undertaken to unravel their role during bacterial infection with in parts contradictory 
results, showing beneficial as well as detrimental functions of MCs in the course and outcome 
of infectious diseases. This thesis clearly demonstrates a protective role of MCs against E. 
faecalis mediated by extracellular processes: (1) the release of so called mast cells 
extracellular traps (MCETs) that are able to ensnare and kill bacteria and (2) by the release of 
pre-stored antimicrobial peptides that are directly antimicrobial.  
The cathelicidin LL-37 was identified as the antimicrobial agent responsible to induce cell 
wall stress and vesicle formation on the bacterial membrane of E. faecalis.  
Furthermore, the importance of the TLR/MyD88 signaling pathway in the response of MC to 
E. faecalis could be strengthened by using MCs deficient in the expression of MyD88 and 
TLR2.  
DCs in comparison to MCs were found to be able to phagocytize and kill E. faecalis. 
Furthermore, they release a cytokine milieus consisting amount of important 
immunomodulatory molecules like IL-12, but also mediators like KC or MIP2, belonging to 
the CXC chemokine family. KC and MIP2 are of central importance for the recruitment of 
PMNs and macrophages, both innate immune cell types essential for clearance of E. faecalis.  
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Interestingly, it could be determined that the TLR2/MyD88 pathway is also important for the 
induction of cell maturation and the release of cytokines and chemokines underlining a key 
role of this PRR sensing pathway in the immune response towards enterococci.   
Upon entry into the blood stream, E. faecalis faces the endothelial cell barrier of the host, 
separating the blood from deeper tissue layers. Another important function of endothelial cells 
is the production of cytokines and chemokine during bacterial infections. Additionally, the 
endothelium is involved in a process called leukocyte extravasation which is taking place at 
the endothelial layer and is mediated by the expression of endothelial surface receptors like 
ICAM-1, E-selectin and VCAM-1. This study provides for the first time evidence, that E. 
faecalis interferes with the expression of these receptors and therefore blocks adhesion and 
transmigration of leukocytes through the endothelial barrier.  
These findings in combination with others findings like the diminished IL-8 response 
strengthen a manipulation of the endothelium by E. faecalis. This might be a new and 
interesting process by which these bacteria evade immune responses by the host and facilitate 
colonization and infection of the endothelial barrier. Factors produced by enterococci to 
achieve this manipulation warrant further investigations. 
In summary, the study presented here provided a novel insight into the innate immune 
mechanism involved in the response to this emerging pathogen. It highlights the molecular 
and cellular processes involved in the natural resistance to these microorganism as well as the 
defense strategies utilized by E. faecalis in the conversion of an opportunistic commensal into 
a pathogenic organism that is able to colonize the host and induce potentially life threatening 
diseases. 
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Abbreviations 
 
°C   degree Celsius  
3´   three prime end 
5´   five prime end 
APC   Allophycocyanin 
APCs   antigen-presenting cells 
BEA   bile esculin agar 
BSA   bovine serum albumin 
BHI   brain heart infusion 
BMMC  bone marrow mast cells 
BSS   balanced salt solution 
C3   complement component 3 
CCL   chemokine (C-C-motif) ligand 
CD   cluster of differentiation  
cDNA   copy deoxyribonucleic acid 
CFU   colony forming units 
CO2   carbon dioxide 
Comp 48/80   Compound 48/80 
CpG   cytosine-phosphate-guanine 
Cromolyn   5.5′-(2-hydroxypropane-1.3-diyl)di(oxy)di(4-oxo-4H-chromene-2-
   carboxylic acid) 
CTR   control  
CXCL   chemokine (C-X-C-motif) ligand 
DAMPs  danger-associated molecular patterns  
DC   dendritic cell 
DMEM  Dulbecco's Modified Eagle's Medium 
DNA   deoxyribonucleic acid 
DTNB   5-(3-Carboxy-4-nitrophenyl)disulfanyl-2-nitrobenzoic acid 
EBM-1  Endothelia Basal Medium-1 
EBM-2  Endothelia Basal Medium-2 
ECM   Endothelia cell medium 
EDTA   ethylenediaminetetraacetic acid 
E. faecalis  Enterococcus faecalis 
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EGM-1  Endothelia Growth Medium-1 
EGM-2  Endothelia Growth Medium-2 
ELISA   enzyme linked immunosorbent assay 
et al    et alii (Latin ‘and others’) 
FACS   Fluorescence-activated cell sorting 
FCS   fetal calf serum 
FIG   figure 
FITC   Fluorescein isothiocyanat 
g   gram 
GFP   green-fluorescent protein 
GM-CSF  granulocyte macrophage colony-stimulating factor 
h     hour 
h.i.    heat-inactivated  
H2O   water 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
FCS   fetal calf serum 
IC   intracellular 
IFN   interferon 
IL   interleukin 
IMDM   Iscove's Modified Dulbecco's Medium 
l   liter 
LPS   lipopolysaccaride 
LTA   lipoteichoic acid 
log   logarithm   
M   molar  
MCET   mast cell extracellular trap 
MFI   mean fluorescence intensity 
mg   milligram 
MHC    major histocompatibility complex 
min    minute 
ml    milliliter 
mM   millimolar 
MOI   multiplicity of infection 
MQ   MilliQ 
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MyD88 
-/-
  diploid myd88-gene knock-out  
mSCF   murine stem-cell factors 
MSCRAMM   Microbial surface component recognizing adhesive matrix molecule 
NaCl   sodium chloride 
NaN3   sodium azide 
NEAA   non-essential amino acids 
NET   neutrophil extracellular traps 
ng   nanogram 
nm   nanometer 
NOD    non-obese diabetic 
NF-κB   nuclear factor-κB  
OD600nm  optical density at 600 nm 
ON   over night 
PAMPs  pathogen associated molecular patterns 
PBS   phosphate buffered saline 
PBST   phosphate buffered saline plus Tween20 
PCR    polymerase chain reaction 
PE    phycoerythrin 
PFA   paraformaldehyde 
pg   pictogram 
PRR   pattern-recognition receptor 
P value   probability value 
RIG-1   retinoic acid-inducible gene 1 
RNA   ribonucleic acid 
ROS   reactive oxide species 
rpm    rotations per minute 
RPMI    Roswell park memorial institute medium 
RT   room temperature 
SD    standard deviation 
TAE   Tris-acetate-EDTA 
TF   tissue factor 
TGF   transforming growth factor 
TLR2 
-/-
  diploid tlr2-gene knock-out  
TMB   3.3'.5.5'-tetramethylbiphenyl-4.4'-diamine 
 x 
 
TPA   12-O-tetradecanoylphorbol-13-acetate 
Tween-20   Polyoxyethylene Sorbitan Monolaurate 
WT   wild type 
α   alpha 
β   beta 
γ   gamma 
ε   epsilon  
κ   kappa 
x g   gravitational acceleration  
µg   microgram 
µl   microliter 
µm   micrometer 
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Table 9.  Gene profile of virulence factors in Enterococcus faecalis 
 
internal name disease pattern source ace as clyA β-hemolysis elyA esp ebpA ebpB ebpC efaA gelE hyl 
E. faecalis 1 blood Hospital BS + + - - - + + + + + + + 
E. faecalis 11 blood Hospital BS + + - - - + + + + + + - 
E. faecalis 13 blood Hospital BS + + + - - + + + + + + - 
E. faecalis 15 blood Hospital BS + + + - - + + + + + + - 
E. faecalis 18 blood Hospital BS + + - - + + + + + + + + 
E. faecalis 20 blood Hospital BS + + + - - + + + + + + - 
E. faecalis 5 blood Hospital BS + + - - - + + + + + + + 
E. faecalis 8 blood Minneapolis + + + + + - + + + + + + + 
E. faecalis 2 bone Hospital BS + + + - - - + + + + + - 
E. faecalis 14 endocarditis Hospital BS + + + - - + + + + + + - 
E. faecalis 19 endocarditis Hospital BS + + + - + - + + + + + - 
E. faecalis 21 endocarditis Hospital BS + + - - - + + + + + + + 
E. faecalis 29 endocarditis Hospital BS + + + - - + + + + + + + 
E. faecalis 3 endocarditis & sepsis Hospital BS + + + - - + + + + + + - 
E. faecalis 10 AHJ transplantation infection Hospital BS + + - - - + + + + + + + 
E. faecalis 12 AHJ transplantation infection Hospital BS + + + - - + + + + + + - 
E. faecalis 22 AHJ transplantation infection Hospital BS + + + + - + + + + + + + 
E. faecalis 4 AHJ transplantation infection Hospital BS + + + - - + + + + + + - 
E. faecalis 6 AHJ transplantation infection Hospital BS + + + - - + + + + + + - 
E. faecalis 7 AHJ transplantation infection Hospital BS + + - - - + + + + + + - 
E. faecalis 
OG1RF 
lab strain DSMZ + - - - - - + + + + + - 
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